{
  "meta": {
    "title": "00054_Late_Night_Pyq_Pyt_Marathon_-_54",
    "url": "https://brainandscalpel.vercel.app/00054-late-night-pyq-pyt-marathon-54-9a73a141.html",
    "scrapedAt": "2025-11-29T17:24:59.534Z"
  },
  "questions": [
    {
      "id": 5742,
      "choices": [
        {
          "id": 22940,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Conisation</span></span></span></p>"
        },
        {
          "id": 22941,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cryotherapy</span></span></span></p>"
        },
        {
          "id": 22942,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Targeted biopsy</span></span></span></p>"
        },
        {
          "id": 22943,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pap smear</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 40-year-old woman comes with a history of postcoital bleeding and a visible mass seen in cervix per speculum. The next step to be done?&nbsp;</span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(INICET NOV 2017)</span></span></span></span></p>",
      "unique_key": "Q1181897",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606734,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Targeted biopsy</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A targeted biopsy (punch biopsy) is the next line of management in the above case as the patient is symptomatic (postcoital bleeding) and has a visible lesion. This approach allows for the direct sampling of the lesion to assess for malignancy or other pathological changes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Conisation:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Conisation is an excisional procedure that is typically performed once biopsy-proven cervical intraepithelial neoplasia (CIN 2 and 3) is diagnosed. It is not the initial step for a visible mass with postcoital bleeding.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Cryotherapy:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Cryotherapy is an ablative procedure used for treating CIN1 or 2. It is not suitable for initial diagnosis or for lesions suspected of being malignant.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Pap smear:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A Pap smear is done when there are symptoms with no identifiable lesion. It is a screening tool and not diagnostic for a visible lesion with postcoital bleeding.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a symptomatic patient with a visible cervical lesion and postcoital bleeding, a targeted biopsy is the appropriate next step to obtain a definitive diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 327, DC Dutta&rsquo;a Textbook of gynecology, 6<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 22942,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20487,
      "choices": [
        {
          "id": 81910,
          "text": "<p><span style=\"font-size:12pt;\">Oral methotrexate</span></p>"
        },
        {
          "id": 81911,
          "text": "<p><span style=\"font-size:12pt;\">Single-dose methotrexate injection</span></p>"
        },
        {
          "id": 81912,
          "text": "<p><span style=\"font-size:12pt;\">Serial methotrexate + leucovorin rescue</span></p>"
        },
        {
          "id": 81913,
          "text": "<p><span style=\"font-size:12pt;\">Salpingectomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A female presents to OPD with 6 weeks of amenorrhea complaints of bleeding per vagina and mild abdominal pain. The urine pregnancy test is positive and hCG level is 2800 IU/L. On investigation, mass is seen on the left adnexa measuring 3 x 2 cm. She is hemodynamically stable. How will you manage this patient?&nbsp;(NEET PG 2023)</span></p>",
      "unique_key": "Q8338569",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606735,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Single-dose methotrexate injection</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The clinical scenario presented indicates an unruptured ectopic pregnancy. The patient is hemodynamically stable, and the hCG level is 2800 IU/L with an adnexal mass measuring 3 x 2 cm. These findings meet the criteria for medical management of an ectopic pregnancy with methotrexate. Single-dose methotrexate injection is an appropriate treatment choice for an unruptured ectopic pregnancy when the patient is stable, has no significant symptoms, and the gestational sac is less than 3.5 cm in size without visible cardiac activity. Methotrexate is a folic acid antagonist that inhibits DNA synthesis and cell replication, effectively treating the ectopic pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Oral methotrexate:</strong> Oral methotrexate is not a standard treatment protocol for ectopic pregnancy. Methotrexate for ectopic pregnancy is typically administered via injection to ensure proper dosage and effectiveness.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Serial methotrexate + leucovorin rescue:</strong> This multidose protocol is used for ectopic pregnancies with higher hCG levels or when the single-dose protocol is contraindicated or has failed. However, it is more complex and involves multiple injections and monitoring.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Salpingectomy:</strong> Surgical management, such as salpingectomy, is indicated for ectopic pregnancies with significant pain, adnexal masses larger than 35 mm, visible fetal heartbeat, or serum hCG levels of 5000 IU/L or more. In this case, the patient’s condition does not meet these criteria, making surgery unnecessary.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Management of Unruptured Ectopic</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/10/screenshot-2024-08-10-180854.png\" alt=\"\" width=\"1000\" height=\"577\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Surgical Management in Unruptured Ectopic –</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Indicated in:</span></p><p>&nbsp;</p><ol style=\"list-style-type:lower-roman;\"><li><span style=\"font-size:12pt;\">an ectopic pregnancy and significant pain</span></li><li><span style=\"font-size:12pt;\">an ectopic pregnancy with an adnexal mass of 35 mm or larger</span></li><li><span style=\"font-size:12pt;\">an ectopic pregnancy with a fetal heartbeat visible on an ultrasound scan</span></li><li><span style=\"font-size:12pt;\">an ectopic pregnancy and a serum hCG level of 5,000 IU/L or more</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12pt;\">&nbsp;Laparoscopy is preferred</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\">SALPINGECTOMY: Preferred if:</span><ul><li><span style=\"font-size:12pt;\">Extensive tubal involvement/ damage</span></li><li><span style=\"font-size:12pt;\">Recurrent ectopic pregnancy in the same tube</span></li><li><span style=\"font-size:12pt;\">Completed family</span></li><li><span style=\"font-size:12pt;\">Ectopic at the site of a previous tubal sterilization</span></li></ul></li><li><span style=\"font-size:12pt;\">SALPINGOSTOMY: (Linear incision on the antimesenteric border with removal of products of conception) Done if a woman wants to conceive in the future.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The management of an unruptured ectopic pregnancy in a hemodynamically stable patient with an hCG level less than 5000 IU/L and an adnexal mass smaller than 3.5 cm is typically treated with a single-dose methotrexate injection.</span></p>",
      "correct_choice_id": 81911,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54772,
      "choices": [
        {
          "id": 218553,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Estrone</span></span></p>"
        },
        {
          "id": 218554,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Estradiol</span></span></p>"
        },
        {
          "id": 218555,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Estriol</span></span></p>"
        },
        {
          "id": 218556,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Conjugated equine estrogen</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The most potent natural estrogen is? (INICET MAY 2024)</span></span></span></p>",
      "unique_key": "Q5996201",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606736,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Estradiol</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Estrogens play a crucial role in the development and regulation of the female reproductive system and secondary sexual characteristics. Among the natural estrogens, estradiol is the most potent. Estradiol is primarily produced by the ovaries and is the predominant estrogen during the reproductive years of a woman. It has the highest affinity for estrogen receptors, making it the most effective at eliciting estrogenic responses in the body.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Estrone, on the other hand, is the main estrogen found in postmenopausal women and is less potent than estradiol. Estriol is the weakest of the three natural estrogens and is predominantly produced during pregnancy. Conjugated equine estrogen is a mixture of estrogens derived from the urine of pregnant mares and is less potent than estradiol.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Therefore, estradiol is considered the most potent natural estrogen due to its strong affinity for estrogen receptors and its significant role in reproductive physiology.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Estrone:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Although it is a natural estrogen, estrone is less potent than estradiol. It is primarily found in postmenopausal women and does not exert the same level of estrogenic activity as estradiol.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Estriol:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This estrogen is the least potent of the natural estrogens and is mainly produced during pregnancy. It has a much lower affinity for estrogen receptors compared to estradiol.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Conjugated equine estrogen:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is a semi-synthetic mixture of estrogens obtained from horses. While it is used in hormone replacement therapy, its potency is lower than that of estradiol and it is not considered a single natural estrogen.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Estradiol is the most potent natural estrogen, especially during a woman&rsquo;s reproductive years, due to its high receptor affinity and significant physiological effects</span></span></span></p>",
      "correct_choice_id": 218554,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5676,
      "choices": [
        {
          "id": 22676,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">10% buffered formalin</span></span></span></p>"
        },
        {
          "id": 22677,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">95% ethyl alcohol</span></span></span></p>"
        },
        {
          "id": 22678,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Air dried</span></span></span></p>"
        },
        {
          "id": 22679,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">None of the above</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fixative for PAP smear:&nbsp;(INICET MAY 2017)</span></span></p>",
      "unique_key": "Q4878922",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606737,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) 95% ethyl alcohol</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The most commonly used fixative for a Pap smear is 95% ethyl alcohol. This fixative preserves the cellular detail necessary for accurate cytological evaluation by preventing cellular autolysis and degradation. The use of 95% ethyl alcohol ensures that the cells maintain their morphology, which is critical for detecting abnormalities such as dysplasia or carcinoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">95% Ethyl Alcohol:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is the standard fixative for Pap smears, ensuring optimal preservation of cellular details.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ethanol Spray:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> In modern practice, an ethanol spray fixative is available, which can be conveniently used in an office setting to fix the smear immediately after it is taken.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. 10% buffered formalin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This fixative is typically used for histological specimens rather than cytological smears like the Pap test.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Air dried:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Air drying is not recommended for Pap smears as it can cause cellular distortion and artifacts, which complicate the interpretation of the smear.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. None of the above:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is incorrect as 95% ethyl alcohol is the correct fixative.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The most commonly used fixative for a Pap smear is 95% ethyl alcohol, which preserves cellular morphology necessary for accurate cytological evaluation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 271, DC Dutta&rsquo;s Textbook of Gynecology 8<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 22677,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61194,
      "choices": [
        {
          "id": 244057,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Multiple pregnancy</span></span></span></p>"
        },
        {
          "id": 244058,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Previous manual removal of the placenta</span></span></span></p>"
        },
        {
          "id": 244059,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pre-eclampsia</span></span></span></p>"
        },
        {
          "id": 244060,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gestational diabetes mellitus</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 32-year-old woman visits her obstetrician for a routine prenatal appointment at 20 weeks of gestation. Which of the following factors would not automatically categorize her current pregnancy as high-risk?</span></span></span></p>",
      "unique_key": "Q9045229",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606738,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. Previous manual removal of the placenta</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Previous manual removal of the placenta, although a significant event, does not automatically place subsequent pregnancies in the high-risk category unless it is associated with other conditions such as uterine scarring, placenta accreta, or other complications. High-risk pregnancies are typically defined by factors that pose a significant risk to the mother or fetus, including chronic health conditions, certain pregnancy-related complications, or lifestyle factors.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Multiple pregnancy:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Pregnancies involving more than one fetus (e.g., twins or triplets) are automatically considered high-risk due to the increased likelihood of complications such as preterm birth, pre-eclampsia, and fetal growth restriction.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Pre-eclampsia:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> A pregnancy disorder characterized by high blood pressure and signs of damage to another organ system, often the kidneys. It significantly increases the risk for both the mother and fetus, including the risk of preterm delivery and placental abruption.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Gestational diabetes mellitus:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This condition occurs when a woman develops high blood glucose levels during pregnancy. It can lead to complications such as macrosomia (large for gestational age baby), increased risk of cesarean delivery, and future risk of type 2 diabetes for both the mother and child.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">High-risk pregnancies are defined by factors that increase the risk of complications for the mother or fetus, such as chronic health conditions, pregnancy-specific disorders, and certain lifestyle factors. Previous manual removal of the placenta does not automatically classify a subsequent pregnancy as high-risk unless associated with other complications.</span></span></span></p>",
      "correct_choice_id": 244058,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6051,
      "choices": [
        {
          "id": 24174,
          "text": "<p><span style=\"font-size:12pt;\">Renal agenesis</span></p>"
        },
        {
          "id": 24175,
          "text": "<p><span style=\"font-size:12pt;\">Tracheosophageal fistula</span></p>"
        },
        {
          "id": 24176,
          "text": "<p><span style=\"font-size:12pt;\">Cardiac abnormalities</span></p>"
        },
        {
          "id": 24177,
          "text": "<p><span style=\"font-size:12pt;\">Ureteral stricture</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A woman at 26 weeks of gestation presents for routine evaluation. On examination, fundal height corresponds to 24 weeks. Ultrasonography revealed decreased amniotic fluid. Which of the following conditions would have led to this presentation?&nbsp;</span>(NEET PG 2022)</p>",
      "unique_key": "Q5854102",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606739,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Renal agenesis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12pt;\">Early onset oligohydramnios can be due to renal anomalies like:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\"><strong>Bilateral renal agenesis</strong>: Absence of both kidneys, leading to a lack of urine production, which is a major component of amniotic fluid.</span></li><li><span style=\"font-size:12pt;\"><strong>Bilateral dysplastic kidneys</strong>: Kidneys that do not function properly, also leading to reduced urine output.</span></li><li><span style=\"font-size:12pt;\"><strong>Bilateral autosomal recessive infantile polycystic kidney disease</strong>: This genetic disorder causes the kidneys to develop cysts, impairing their function.</span></li><li><span style=\"font-size:12pt;\"><strong>Complex genito-urinary anomalies</strong>: Conditions like persistent cloaca and sirenomelia can affect kidney and urinary tract development, leading to oligohydramnios.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Tracheoesophageal Fistula:&nbsp;</strong>Tracheoesophageal fistula typically leads to <strong>polyhydramnios</strong> due to an obstruction to swallowing, resulting in an accumulation of amniotic fluid.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Cardiac Abnormalities:&nbsp;</strong>Cardiac abnormalities usually lead to cardiac failure, which can result in fetal hydrops and <strong>polyhydramnios</strong> due to fluid accumulation in various fetal compartments.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Ureteral Stricture:&nbsp;</strong>Ureteral stricture will not lead to oligohydramnios unless there is bilateral involvement, which would be less common than the systemic impact of renal agenesis or other significant renal anomalies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Early onset oligohydramnios can be caused by renal anomalies, with bilateral renal agenesis being a primary condition leading to reduced amniotic fluid levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 670, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 24174,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23224,
      "choices": [
        {
          "id": 92860,
          "text": "<p><span style=\"font-size:12pt;\">Uterine prolapse - Vaginal hysterectomy</span></p>"
        },
        {
          "id": 92861,
          "text": "<p><span style=\"font-size:12pt;\">Vault prolapse - Sacrospinous ligament suspension</span></p>"
        },
        {
          "id": 92862,
          "text": "<p><span style=\"font-size:12pt;\">Cystocele - Colposuspension</span></p>"
        },
        {
          "id": 92863,
          "text": "<p><span style=\"font-size:12pt;\">Rectocele - Posterior colporrhaphy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following options is incorrectly matched?&nbsp;</span>(INICET MAY 2023)</p>",
      "unique_key": "Q6820595",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606740,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Cystocele - Colposuspension</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Anterior colporrhaphy is performed for cystocele.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/05/screenshot-2024-08-05-101304.png\" alt=\"\" width=\"1000\" height=\"420\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">For cystocele, the appropriate surgical management is anterior colporrhaphy, not colposuspension.</span></p>",
      "correct_choice_id": 92862,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5794,
      "choices": [
        {
          "id": 23147,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Placenta membranacea</span></span></span></p>"
        },
        {
          "id": 23148,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Placenta succenturiata</span></span></span></p>"
        },
        {
          "id": 23149,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Circummarginate placenta</span></span></span></p>"
        },
        {
          "id": 23150,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Circumvallate placenta</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A pregnant woman delivered a baby with the normal expulsion of an intact placenta. After half an hour she started bleeding per vaginal. On examination, she was hypotensive, and a boggy mass was palpated per abdomen. Ultrasound showed retained placental tissues. What is the likely diagnosis?&nbsp;</span></span>(INICET MAY 2018)</p>",
      "unique_key": "Q7236335",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606741,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Placenta succenturiate</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is mentioned here that the placenta expelled looked normal and intact</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In such a case, if there is a retained component, it could be a succenturiate lobe </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Placenta succenturiata refers to a placenta with an additional lobe/lobes of placental tissue located a few centimeters away.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The ancillary lobes can be associated with complications such as placenta previa, vasa previa, postpartum hemorrhage or infection.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/18/picture3.jpg\" style=\"height:190px; width:300px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Placenta membranacea: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Placenta membranacea is a rare placental disorder characterized by the presence of fetal membranes (complete or partially) covered by chorionic villi. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Associated with painless vaginal bleeding in the second and third trimester</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This condition can be associated with other placental abnormalities, such as placenta previa or accreta.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Perinatal outcome may include stillbirth, preterm delivery, or neonatal death.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/18/picture4.jpg\" style=\"height:224px; width:300px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Circummarginate placenta: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Uncommon&nbsp;variation in placental morphology in which a thin fibrous ring is present at the margin of the chorionic plate where the fetal vessels appear to terminate.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The placenta is unduly large and thin. The placenta not only develops from the chorion frondosum but also from the chorion laeve so that the whole of the ovum is practically covered by the placenta</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Associated with Abortion, Hydrorrhea gravidarum (excessive watery vaginal discharge), Antepartum hemorrhage, Growth retardation of the baby, Preterm delivery and Retained placenta or membranes.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/18/picture5.jpg\" style=\"height:300px; width:300px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Circumvallate placenta: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The fetal surface is divided into a central depressed zone surrounded by a thickened white ring which is usually complete. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The ring is situated at varying distances from the margin of the placenta. The ring is composed of a double fold of amnion and chorion with degenerated decidua (vera) and fibrin in between </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vessels radiate from the cord insertion as far as the ring and then disappear from view </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The peripheral zone outside the ring is thicker and the edge is elevated and rounded.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/18/picture6.jpg\" style=\"height:252px; width:300px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Placenta succenturiata is characterized by an additional lobe of placental tissue separate from the main placenta, which can be retained postpartum, leading to hemorrhage and requiring careful monitoring and management.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 253, DC Dutta&rsquo;s Textbook of Obstetrics 8<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23148,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44017,
      "choices": [
        {
          "id": 175727,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oral contraceptive pills (OCPs)</span></span></span></p>"
        },
        {
          "id": 175728,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Functional ovarian cyst</span></span></span></p>"
        },
        {
          "id": 175729,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nulliparity</span></span></span></p>"
        },
        {
          "id": 175730,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Polycystic ovary syndrome (PCOS)</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is a risk factor for progression to borderline ovarian tumor?</span></span>&nbsp;(INICET NOV 2023)</p>",
      "unique_key": "Q4629286",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606742,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Nulliparity</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nulliparity is associated with a slightly increased risk of ovarian tumors, including borderline ovarian tumors, possibly due to uninterrupted ovulation and hormonal fluctuations.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Oral contraceptive pills (OCPs:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Oral contraceptive pills (OCPs) are known to reduce the risk of ovarian cancer.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Functional ovarian cyst:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Functional ovarian cysts typically do not progress to ovarian tumors.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Polycystic ovary syndrome (PCOS):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Polycystic ovary syndrome (PCOS) has not been strongly linked with increased risk of borderline ovarian tumors.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nulliparity is recognized as a risk factor for borderline ovarian tumors, highlighting the influence of reproductive factors on ovarian health.</span></span></span></p>",
      "correct_choice_id": 175729,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5879,
      "choices": [
        {
          "id": 23486,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fetal movement</span></span></span></p>"
        },
        {
          "id": 23487,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fetal breathing</span></span></span></p>"
        },
        {
          "id": 23488,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">NST</span></span></span></p>"
        },
        {
          "id": 23489,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Contraction stress test</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is not a component of fetal biophysical profile?&nbsp;</span></span>(INICET MAY 2020)</p>",
      "unique_key": "Q1775858",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606743,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Contraction stress test</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The fetal biophysical profile (BPP) is a comprehensive assessment used to evaluate fetal well-being, and it includes five components:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">NST (Non-Stress Test):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Evaluates fetal heart rate reactivity.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amniotic Fluid Volume (AFV):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Assessed through ultrasound to check the amount of amniotic fluid.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fetal Movement:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Observes fetal movements through ultrasound.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fetal Tone:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Evaluates the presence of fetal muscle tone and limb movements.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fetal Breathing:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Assesses the presence and duration of fetal breathing movements.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>Contraction Stress Test (CST)</strong> is not part of the BPP. Instead, it is a separate test used to assess the fetal heart rate response to uterine contractions, helping to evaluate how well the fetus handles the stress of contractions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Fetal movement:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is a component of the BPP, assessing the number of fetal movements.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Fetal breathing:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is a component of the BPP, evaluating the presence of fetal breathing movements.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. NST:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The Non-Stress Test is a key component of the BPP, measuring fetal heart rate reactivity to movements.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The Contraction Stress Test is not a component of the fetal biophysical profile.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 122, DC Dutta&rsquo;s Textbook of Obstetrics 8<sup>th</sup> edition </span></strong></span></span></p>",
      "correct_choice_id": 23489,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5897,
      "choices": [
        {
          "id": 23558,
          "text": "<p><span style=\"font-size:12pt;\">106 mg/dL</span></p>"
        },
        {
          "id": 23559,
          "text": "<p><span style=\"font-size:12pt;\">126 mg/dL</span></p>"
        },
        {
          "id": 23560,
          "text": "<p><span style=\"font-size:12pt;\">116 mg/dL</span></p>"
        },
        {
          "id": 23561,
          "text": "<p><span style=\"font-size:12pt;\">130 mg/dL</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">You discover that there is evidence of cardiac malformation in a fetus during a routine US scan at 16 weeks. What is the minimum level of fasting blood sugar at which you can suspect overt diabetes?&nbsp;</span>(NEET PG 2019)</p>",
      "unique_key": "Q8189139",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606744,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) 126 mg/dL</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Overt diabetes in a patient is diagnosed based on specific blood glucose levels. The criteria for diagnosing overt diabetes are:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Fasting blood sugar:</strong> ≥ 126 mg/dL</span></li><li><span style=\"font-size:12pt;\"><strong>Random blood sugar:</strong> ≥ 200 mg/dL</span></li><li><span style=\"font-size:12pt;\"><strong>HbA1c:</strong> ≥ 6.5%</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">During pregnancy, maternal hyperglycemia, especially during the first trimester when organogenesis occurs, increases the risk of fetal congenital malformations, including cardiac malformations. This is particularly true for women with pre-gestational diabetes, not gestational diabetes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. 106 mg/dL</strong>: This is incorrect. A fasting blood sugar level of 106 mg/dL does not meet the threshold for diagnosing overt diabetes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. 116 mg/dL</strong>: This is incorrect. A fasting blood sugar level of 116 mg/dL is higher than normal but still below the threshold for diagnosing overt diabetes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. 130 mg/dL</strong>: This is incorrect. Although higher than the threshold, the minimum level to suspect overt diabetes is 126 mg/dL, not 130 mg/dL.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Overt diabetes in pregnancy is diagnosed with a fasting blood sugar level of ≥ 126 mg/dL, and maternal hyperglycemia.</span></p>",
      "correct_choice_id": 23559,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "DiagnosisBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61188,
      "choices": [
        {
          "id": 244033,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Beta HCG and PAPP-A</span></span></span></p>"
        },
        {
          "id": 244034,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Unconjugated estradiol and PAPP-A</span></span></span></p>"
        },
        {
          "id": 244035,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">AFP and Inhibin A</span></span></span></p>"
        },
        {
          "id": 244036,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">AFP and Beta HCG</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which test is used for screening Down&rsquo;s syndrome in the first trimester? (AIIMS NOV 2016)</span></span></span></p>",
      "unique_key": "Q6634083",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606745,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Beta HCG and PAPP-A</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In the first trimester, screening for Down&rsquo;s syndrome involves measuring two specific analytes: human chorionic gonadotropin (hCG) and pregnancy-associated plasma protein A (PAPP-A). In cases of Down&rsquo;s syndrome, the first-trimester serum levels of free &beta;-hCG are typically elevated (around 2.0 MoM), while PAPP-A levels are lower (around 0.5 MoM). These markers are effective in detecting fetal Down&rsquo;s syndrome, particularly when combined with the nuchal translucency (NT) measurement or second-trimester analytes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Unconjugated estradiol and PAPP-A</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> - This combination is not used for first-trimester screening of Down&rsquo;s syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>C. AFP and Inhibin A</strong> - These markers are typically used in second-trimester screening.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. AFP and Beta HCG</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> - While these markers are useful in certain screenings, they are not the primary markers for first-trimester Down&rsquo;s syndrome screening.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">First-trimester screening for Down&rsquo;s syndrome primarily involves measuring Beta hCG and PAPP-A levels.</span></span></span></p>",
      "correct_choice_id": 244033,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6008,
      "choices": [
        {
          "id": 24002,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1, 2, 3, 4 and 5</span></span></span></p>"
        },
        {
          "id": 24003,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1, 2 and 5</span></span></span></p>"
        },
        {
          "id": 24004,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2, 3, 4 and 5</span></span></span></p>"
        },
        {
          "id": 24005,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1, 3 and 5</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A couple already has 3 children and has been trying for another one for the last 1 year. However, the husband is diagnosed with hypogonadotropic hypogonadism. Which of the following is/are true?&nbsp;</span></span></span>(INICET MAY 2022)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Low FSH, low LH</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">High FSH, low LH</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oligospermia</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Low prolactin</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Low testosterone</span></span></span></li>\r\n</ol>",
      "unique_key": "Q7270098",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606846,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) 1, 3 and 5 </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypogonadotropic hypogonadism is a condition where there is decreased production of gonadotropins (FSH and LH) by the pituitary gland, leading to decreased stimulation of the testes and consequent reduced production of sex hormones such as testosterone. This results in:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1. Low FSH, low LH:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> In hypogonadotropic hypogonadism, both follicle-stimulating hormone (FSH) and luteinizing hormone (LH) are low due to inadequate stimulation from the pituitary gland.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">3. Oligospermia:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Reduced levels of FSH and LH lead to decreased stimulation of the testes, which can result in reduced sperm production and oligospermia (low sperm count).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">5. Low testosterone:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Hypogonadotropic hypogonadism leads to reduced levels of testosterone because the testes are not adequately stimulated by FSH and LH.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The following are not true for hypogonadotropic hypogonadism:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2. High FSH, low LH:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This pattern is more characteristic of hypergonadotropic hypogonadism (primary testicular failure) rather than hypogonadotropic hypogonadism.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">4. Low prolactin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Hypogonadotropic hypogonadism is typically associated with normal or high levels of prolactin if there is an underlying pituitary issue. Low prolactin is not a characteristic feature of hypogonadotropic hypogonadism.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In hypogonadotropic hypogonadism, both FSH and LH levels are low, testosterone levels are low, and oligospermia is often present.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 232, DC Dutta&rsquo;s Textbook of Gynecology, 6<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 24005,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5815,
      "choices": [
        {
          "id": 23230,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Unmotivated patient</span></span></span></p>"
        },
        {
          "id": 23231,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Menorrhagia</span></span></span></p>"
        },
        {
          "id": 23232,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Previous ectopic pregnancy</span></span></span></p>"
        },
        {
          "id": 23233,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Previous history of abortion</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following would be considered as an absolute contraindication for insertion of copper T to a patient?&nbsp;</span></span>(INICET NOV 2018)</p>",
      "unique_key": "Q3361062",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606847,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Unmotivated patient</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inserting a copper T intrauterine device (IUD) requires the patient to be motivated and consent to the procedure. An unmotivated patient or one who does not consent should never undergo the procedure. This is because the successful use of an IUD requires patient understanding, willingness to comply with follow-up care, and adherence to guidelines for managing any potential side effects or complications.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Absolute contraindications for the use of copper IUDs include:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Unexplained uterine or vaginal bleeding</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Post-abortal sepsis, puerperal sepsis, current pelvic inflammatory disease (PID), or genital tuberculosis</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cancers such as endometrial cancer, cervical cancer, and gestational trophoblastic neoplasia</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Large fibroids distorting the uterine cavity or Mullerian anomalies distorting the uterine cavity</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Menorrhagia:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While menorrhagia is a relative contraindication, as the copper IUD can exacerbate heavy menstrual bleeding, it is not an absolute contraindication.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Previous ectopic pregnancy:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A history of ectopic pregnancy is a consideration but not an absolute contraindication for copper IUD use.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Previous history of abortion:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A previous history of abortion is not an absolute contraindication for the insertion of a copper IUD.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An unmotivated patient or one who does not consent is an absolute contraindication for the insertion of a copper T intrauterine device (IUD).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Dutta&rsquo;s textbook of gynecology 6th edition pg 480</span></strong></span></span></p>",
      "correct_choice_id": 23230,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6072,
      "choices": [
        {
          "id": 24258,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1st trimester USG is the best assessment</span></span></span></p>"
        },
        {
          "id": 24259,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Calculated from the last day of the last menstrual period</span></span></span></p>"
        },
        {
          "id": 24260,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In an IVF pregnancy, day of embryo transfer/day of fertilization is needed to calculate POG</span></span></span></p>"
        },
        {
          "id": 24261,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Crown-rump length is the best measure of period of gestation in the first trimester</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the wrong statement regarding the period of gestation calculation:</span></span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&nbsp;</span></span></span>(INICET NOV 2022)</p>",
      "unique_key": "Q4768891",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606848,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Calculated from the last day of the last menstrual period</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gestational age or period of gestation (POG) refers to the duration of pregnancy calculated from the first day of last menstrual period </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Calculating the EDD: </span></strong></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Normal duration of pregnancy: 280 days (40 weeks)</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Calculating the EDD: <strong>Naegele&rsquo;s formula</strong>. To the LMP (1<sup>st</sup> day of the last menstrual day) </span></span></span>\r\n\t\t<ul>\r\n\t\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Add 9 months + 7 days</span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Subtract 3 months and add 7 days</span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For IVF Pregnancies: add 38 weeks to the date of the embryo transfer</span></span></span></li>\r\n\t\t</ul>\r\n\t\t</li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dating the pregnancy:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> If discrepancy in dates/ unsure of LMP; the best way to determine the dating is by ULTRASOUND</span></span></span>\r\n\t\t<ul>\r\n\t\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1st trimester CRL: most accurate (till 14 weeks)</span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BPD in the 2nd trimester</span></span></span></li>\r\n\t\t</ul>\r\n\t\t</li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. 1st trimester USG is the best assessment</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Correct, because the 1st trimester USG provides the most accurate dating method.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. In an IVF pregnancy, day of embryo transfer/day of fertilization is needed to calculate POG</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Correct, because calculating gestational age in IVF pregnancies relies on the day of embryo transfer or fertilization.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>Crown-rump length is the best measure of period of gestation in the first trimester</strong>: Correct, because CRL is the best measure for assessing the period of gestation in the first trimester.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gestational age is calculated from the first day of the last menstrual period (LMP), not the last day.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: William&rsquo;s textbook of obstetrics 24<sup>th</sup> edition pg, Dutta&rsquo;s 108, 109, textbook of obstetrics 8<sup>th</sup> edition pg127</span></strong></span></span></p>",
      "correct_choice_id": 24259,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5961,
      "choices": [
        {
          "id": 23814,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Overflow incontinence</span></span></span></p>"
        },
        {
          "id": 23815,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Urge incontinence</span></span></span></p>"
        },
        {
          "id": 23816,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stress incontinence</span></span></span></p>"
        },
        {
          "id": 23817,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neurogenic bladder</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 56-year-old multipara woman presented with grade II/III uterine prolapse with cystocele. She complains of passing urine on coughing and sneezing. What is the type of urinary incontinence seen in this patient?</span></span>&nbsp;(NEET PG 2021)</p>",
      "unique_key": "Q4266109",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606849,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Stress incontinence </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stress urinary incontinence is characterized by the involuntary leakage of urine due to increased intra-abdominal pressure, such as during coughing, sneezing, or physical exertion. It is commonly seen in women with utero-vaginal prolapse, where the support structures of the pelvic floor are weakened, leading to bladder dysfunction.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Overflow incontinence:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Overflow incontinence occurs when the bladder cannot empty properly, leading to frequent or constant dribbling of urine. It is usually secondary to an obstruction, such as an enlarged prostate in men or severe prolapse in women causing a kink in the urethra. This condition does not typically present with leakage during activities that increase intra-abdominal pressure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Urge incontinence:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Urge incontinence is the involuntary leakage of urine accompanied by or immediately preceded by a sudden, intense urge to urinate. This type of incontinence can be due to overactive bladder syndrome, where there is involuntary contraction of the bladder muscles.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Neurogenic bladder:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Neurogenic bladder refers to a dysfunction of the urinary bladder due to a central or peripheral nervous system pathology. This can result in various types of incontinence, including both overflow and urge incontinence, depending on the nature of the neurological impairment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stress urinary incontinence is characterized by involuntary leakage of urine due to increased intra-abdominal pressure and is commonly seen in women with utero-vaginal prolapse.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 597, DC Dutta&rsquo;s Textbook of Gynecology 6<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23816,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5928,
      "choices": [
        {
          "id": 23682,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mandatory episiotomy</span></span></span></p>"
        },
        {
          "id": 23683,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Manual perineal support and warm compresses</span></span></span></p>"
        },
        {
          "id": 23684,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Maintain head in deflexion and deliver</span></span></span></p>"
        },
        {
          "id": 23685,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Deliver in lithotomy position only</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is recommended by the WHO for the management of the second stage of labor?&nbsp;</span></span>(INICET MAY 2021)</p>",
      "unique_key": "Q5516794",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606850,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Manual perineal support and warm compresses</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"><br />\r\n<span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The WHO guidelines for managing the second stage of labor emphasize techniques to reduce perineal trauma and enhance maternal comfort. The use of manual perineal support and warm compresses is recommended to protect the perineum during delivery and reduce the incidence of severe perineal tears.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Manual Perineal Support and Warm Compresses:</span></strong></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Manual Support:</span></strong><span style=\"font-size:12.0pt\"> Hands-on guarding of the perineum during delivery helps control the speed of delivery and reduces the risk of severe perineal tears.</span></span></span></li>\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Warm Compresses:</span></strong><span style=\"font-size:12.0pt\"> Applying warm compresses to the perineum can help relax the tissues and make them more pliable, further reducing the risk of tearing.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Mandatory Episiotomy:&nbsp;</span></strong></span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Not Recommended:</span></strong><span style=\"font-size:12.0pt\"> Routine episiotomy is no longer recommended by the WHO. It is only indicated in specific cases where it is necessary to expedite delivery for the safety of the mother or baby.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Maintain Head in Deflexion and Deliver:&nbsp;</span></strong></span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Not Recommended:</span></strong><span style=\"font-size:12.0pt\"> The recommendation is to allow the fetal head to assume the most optimal position for delivery rather than intentionally maintaining deflexion, which may hinder the delivery process.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Deliver in Lithotomy Position Only:&nbsp;</span></strong></span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Not Recommended:</span></strong><span style=\"font-size:12.0pt\"> The WHO supports a variety of birthing positions based on the mother&rsquo;s preference and comfort. Restricting delivery to the lithotomy position is not recommended; instead, women should be encouraged to choose their preferred position.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"><br />\r\n<span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Manual perineal support and warm compresses are recommended by the WHO to reduce perineal trauma during the second stage of labor.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref:&nbsp;</span></strong><a href=\"https://iris.who.int/bitstream/handle/10665/337693/9789240017566-eng.pdf\" style=\"color:#0563c1; text-decoration:underline\"><strong><span style=\"font-size:12.0pt\">https://iris.who.int/bitstream/handle/10665/337693/9789240017566-eng.pdf</span></strong></a></span></span></p>",
      "correct_choice_id": 23683,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5846,
      "choices": [
        {
          "id": 23354,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Epithelial cell with bacteria attached on cell surface</span></span></span></p>"
        },
        {
          "id": 23355,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿Bacteria engulfed by macrophages</span></span></span></p>"
        },
        {
          "id": 23356,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿Neutrophil engulfed bacteria</span></span></span></p>"
        },
        {
          "id": 23357,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿Bacteria arranged in clusters</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 40-year-old female presented with a history of profuse vaginal discharge. The discharge has a fishy odour. Which of the following best describes the microscopic finding given below?&nbsp;</span></span>&nbsp;(INICET MAY 2019)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/02/1_gCJnA5T.jpg\" style=\"height:252px; width:250px\" /></span></span></span></span></span></p>",
      "unique_key": "Q6518223",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606851,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Epithelial cell with bacteria attached on cell surface</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The microscopic finding described is consistent with &quot;clue cells,&quot; which are a hallmark of bacterial vaginosis (BV). Clue cells are vaginal epithelial cells that are covered with a stippled appearance due to bacteria adhering to their surface. This attachment creates a poorly defined border on the cell. Clue cells are significant in diagnosing bacterial vaginosis because they are a reliable indicator of this condition. For a diagnosis of BV, at least 20 percent of epithelial cells in a wet mount preparation should appear as clue cells.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Bacteria engulfed by macrophages:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This finding is more indicative of an inflammatory response and is not characteristic of bacterial vaginosis. It is more commonly associated with other types of infections or inflammatory conditions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Neutrophil engulfed bacteria:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This description is associated with acute bacterial infections or inflammation but not with bacterial vaginosis, where clue cells are the key finding.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Bacteria arranged in clusters:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While bacteria may be present in clusters in some infections, this description does not specifically identify the clue cells characteristic of bacterial vaginosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clue cells, which are epithelial cells with bacteria attached on their surface, are the most reliable microscopic indicator of bacterial vaginosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 554, DC Dutta&rsquo;s Textbook of gynecology 6<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23354,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5979,
      "choices": [
        {
          "id": 23886,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Measure CA 125 levels</span></span></span></p>"
        },
        {
          "id": 23887,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Follow up after 6 weeks</span></span></span></p>"
        },
        {
          "id": 23888,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Laparoscopy</span></span></span></p>"
        },
        {
          "id": 23889,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CT pelvis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 26-year-old woman who has had 2 children through normal delivery presents with a dull aching pain over the abdomen, with irregular menses. Per vaginal examination revealed a mass felt through the posterior fornix. A USG showed a clear ovarian cyst of size 5 x 5 cm. What is the next best step?&nbsp;</span></span>(INICET NOV 2021)</p>",
      "unique_key": "Q8279405",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606852,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Follow up after 6 weeks</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A clear ovarian cyst with minimal symptoms and size less than 8 cm in a woman of reproductive age group is most likely a functional ovarian cyst. The next best step in the management of this case is to follow up after 6-12 weeks and perform a repeat USG.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Key Points:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Functional Ovarian Cyst:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> In reproductive-aged women, a clear ovarian cyst less than 8 cm is likely functional.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Follow-Up:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The recommended management is to follow up after 6-12 weeks with a repeat ultrasound to check if the cyst resolves on its own.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Indications for Further Intervention:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Surgical treatment is warranted if there are worrying features, the cyst is greater than 8 cm, there are significant symptoms, or CA-125 levels are raised.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Measure CA 125 levels:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> CA 125 is a marker for epithelial ovarian tumors and is more relevant in postmenopausal women. It has limited role in premenopausal women with clear, simple cysts.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Laparoscopy:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Surgical intervention such as laparoscopy is not immediately necessary for a 5 cm cyst unless there are concerning features or persistence after follow-up.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. CT pelvis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> CT scan is not typically indicated for initial assessment of a simple ovarian cyst detected on ultrasound.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Additional information:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">OC Pills:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Oral contraceptive pills have not been proven effective in treating simple ovarian cysts, though they are often used.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Simple Ovarian Cysts:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Any simple ovarian cyst less than 5 cm without symptoms can be left alone.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For a reproductive-aged woman with a clear ovarian cyst less than 8 cm and minimal symptoms, the best approach is to follow up with a repeat ultrasound after 6-12 weeks, rather than immediate intervention.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: RCOG greentop guideline number 62 , Williams textbook of gynecology 3<sup>rd</sup> edition pg217</span></strong></span></span></p>",
      "correct_choice_id": 23887,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61193,
      "choices": [
        {
          "id": 244053,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Inhibition of ovulation</span></span></span></p>"
        },
        {
          "id": 244054,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increasing the release of Gonadotropin-Releasing Hormone (GnRH)</span></span></span></p>"
        },
        {
          "id": 244055,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Thickening of cervical mucus</span></span></span></p>"
        },
        {
          "id": 244056,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Altering tubal motility</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 24-year-old medical student is attending a lecture on contraceptive methods. During the discussion, the student asks the instructor to explain how oral contraceptive pills (OCPs) prevent pregnancy. The instructor reviews the mechanisms by which OCPs work and addresses a common misconception about their function. At the end of the lecture, the instructor asks Which of the following is NOT a mechanism of action of oral contraceptive pills?</span></span></span></p>",
      "unique_key": "Q3255578",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606853,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans.&nbsp; B. Increasing the release of Gonadotropin-Releasing Hormone (GnRH)</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Oral contraceptive pills (OCPs) prevent pregnancy primarily by inhibiting the release of Gonadotropin-Releasing Hormone (GnRH) from the hypothalamus, which reduces the secretion of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH) from the pituitary gland, thereby preventing ovulation. Additionally, OCPs work by creating a less favorable endometrial environment to prevent implantation, thickening cervical mucus to hinder sperm entry into the uterus, and altering the motility of the fallopian tubes, reducing the likelihood of sperm and ovum meeting. The misconception that OCPs increase GnRH release is incorrect; they actually inhibit it, which is a crucial aspect of their contraceptive action.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Inhibition of ovulation</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: OCPs suppress the hypothalamic-pituitary-ovarian axis, effectively preventing the hormonal cascade that leads to ovulation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Thickening of cervical mucus</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: By increasing the viscosity of cervical mucus, OCPs make it more challenging for sperm to penetrate and reach the egg, contributing to their contraceptive effectiveness.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Altering tubal motility</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: OCPs impact the motility of the fallopian tubes, slowing down the transport of both sperm and eggs, which further reduces the chances of fertilization.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Oral contraceptives prevent pregnancy by inhibiting ovulation, thickening cervical mucus, altering tubal motility, and maintaining a less receptive endometrium. They do not increase the release of Gonadotropin-Releasing Hormone (GnRH); rather, they inhibit it, which is central to their effectiveness in preventing conception.</span></span></span></p>",
      "correct_choice_id": 244054,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5874,
      "choices": [
        {
          "id": 23466,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Malformations</span></span></span></p>"
        },
        {
          "id": 23467,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Polyhydramnios</span></span></span></p>"
        },
        {
          "id": 23468,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fetal Macrosomia</span></span></span></p>"
        },
        {
          "id": 23469,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neonatal Hypoglycemia</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All the followings are seen in Gestational Diabetes Mellitus except:&nbsp;</span></span></span>(INICET NOV 2019)</p>",
      "unique_key": "Q5655355",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606854,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Malformations</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Congenital malformations are not typically seen with Gestational Diabetes Mellitus (GDM); they are more associated with pre-existing overt diabetes mellitus. When diabetes is present and uncontrolled in the first trimester, particularly with an HbA1C greater than 10%, there is a higher risk of congenital malformations. The most commonly affected system is cardiac, with Ventricular Septal Defect (VSD) being the most common anomaly. A very rare but characteristic anomaly associated with severe diabetes is Mermaid syndrome (sirenomelia).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Polyhydramnios:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Polyhydramnios, characterized by an Amniotic Fluid Index (AFI) greater than 25 or a Single Deepest Pocket (SDP) greater than 8, is common in pregnancies complicated by GDM. It results from increased fetal urination due to hyperglycemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Fetal Macrosomia:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Fetal macrosomia, defined as a birth weight greater than 4 kg, is a common complication of GDM. It is associated with excessive fat deposition, particularly around the shoulders, increasing the risk of shoulder dystocia during delivery.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Neonatal Hypoglycemia:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Neonatal hypoglycemia, with blood glucose levels less than 45 mg/dl, is common in infants of mothers with GDM, especially if maternal blood sugar levels were unstable during labor. This occurs because the fetus produces excess insulin in response to maternal hyperglycemia, leading to low blood sugar levels after birth.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Congenital anomalies are not typically seen with Gestational Diabetes Mellitus (GDM); they are associated with pre-existing overt diabetes mellitus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: William&rsquo;s textbook of obstetrics 26<sup>th</sup> edition pg 2787</span></strong></span></span></p>",
      "correct_choice_id": 23466,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5898,
      "choices": [
        {
          "id": 23562,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Declare as complete abortion and follow-up in 15 days</span></span></span></p>"
        },
        {
          "id": 23563,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Admit and observe</span></span></span></p>"
        },
        {
          "id": 23564,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diagnostic laparoscopy</span></span></span></p>"
        },
        {
          "id": 23565,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Follow-up with beta-HCG</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with 6 weeks amenorrhea and a positive pregnancy test came with complaints of lower abdominal pain, moderate bleeding PV. She was hemodynamically stable. On ultrasound, there was no gestational sac in the uterus. Ovaries were normal and no free fluid in the pouch of Douglas. What is the next line of management?&nbsp;</span></span></span>(INICET NOV 2020)</p>",
      "unique_key": "Q4621660",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606855,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Follow-up with beta-HCG</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient presents with symptoms that could indicate either an ectopic pregnancy or an early miscarriage. The absence of a gestational sac in the uterus on ultrasound at 6 weeks&#39; gestation warrants further investigation to determine the location and viability of the pregnancy. The most appropriate next step is to follow up with serial beta-HCG levels.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Key Points:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ectopic Pregnancy vs. Early Miscarriage:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The differential diagnosis includes both ectopic pregnancy and early miscarriage.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serial Beta-HCG Measurement:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Beta-HCG levels typically double every 48-72 hours in a normal early intrauterine pregnancy. An abnormal rise or plateau in beta-HCG levels may indicate an ectopic pregnancy or a failing pregnancy.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ultrasound Follow-up:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> In combination with beta-HCG monitoring, follow-up ultrasounds can help determine if a gestational sac becomes visible in the uterus or elsewhere.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Declare as complete abortion and follow-up in 15 days:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Declaring a complete abortion without further investigation is premature and may miss an ectopic pregnancy, which can have serious complications.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Admit and observe:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While observation is important, serial beta-HCG levels provide critical information that can guide further management decisions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Diagnostic laparoscopy:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is an invasive procedure and is not the first step in stable patients without definitive evidence of ectopic pregnancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For a patient with 6 weeks of amenorrhea, a positive pregnancy test, and no gestational sac visible on ultrasound, the next step is to follow up with serial beta-HCG levels to differentiate between an early intrauterine pregnancy, an ectopic pregnancy, and a miscarriage.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Williams Textbook of obstetrics 24<sup>th </sup>edition pg 356</span></strong></span></span></p>",
      "correct_choice_id": 23565,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5830,
      "choices": [
        {
          "id": 23290,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sheehan&#39;s syndrome</span></span></span></p>"
        },
        {
          "id": 23291,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rotor syndrome</span></span></span></p>"
        },
        {
          "id": 23292,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prolactinoma</span></span></span></p>"
        },
        {
          "id": 23293,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acromegaly</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A woman presents to the OPD with complaints of amenorrhoea for the past year. She has a history of postpartum hemorrhage and lactational failure. What is the probable diagnosis?</span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&nbsp;(NEET PG 2020)</span></span></span></p>",
      "unique_key": "Q8451060",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606856,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Sheehan&rsquo;s syndrome </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The clinical scenario points to a diagnosis of Sheehan&#39;s syndrome.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When postpartum hemorrhage causes vascular thrombosis of the pituitary vessels (pituitary apoplexy) and panhypopituitarism. It is characterized by: </span></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lactation failure - due to prolactin deficiency</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amenorrhea - due to anovulation caused by reduced gonadotropin activity</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Loss of sexual and axillary hair</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypothyroidism - due to decreased TSH secretion</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adrenal insufficiency - due to low ACTH</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Rotor Syndrome</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Also known as Rotor type hyperbilirubinemia, is an autosomal recessive disease and a rare cause of mixed direct (conjugated) and indirect (unconjugated) hyperbilirubinemia. The disease is characterized by non-hemolytic jaundice due to chronic elevation of predominantly conjugated bilirubin</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Prolactinoma</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This will not present lactation failure. Instead, there will be galactorrhea and symptoms like headache, luring of vision due to pressure effects of the prolactinoma. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Acromegaly</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: It is a disorder that results in excess growth of certain parts of the human body. It is caused by excess&nbsp;growth hormone&nbsp;(GH) after the&nbsp;growth plates&nbsp;have closed. The initial symptom is typically enlargement of the hands and feet.&nbsp;There may also be an enlargement of the forehead, jaw, and nose. Other symptoms may include&nbsp;joint pain, thicker skin, deepening of the voice,&nbsp;headaches, and&nbsp;problems with vision. Complications of the disease may include&nbsp;type 2 diabetes,&nbsp;sleep apnea, and&nbsp;high blood pressure. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sheehan&rsquo;s syndrome is characterized by postpartum hemorrhage leading to vascular thrombosis of the pituitary vessels, resulting in panhypopituitarism with symptoms like lactation failure and amenorrhea.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 458, DC Dutta&rsquo;s Textbook of Gynecology 6<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23290,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61189,
      "choices": [
        {
          "id": 244037,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mature teratoma&nbsp; </span></span></span></p>"
        },
        {
          "id": 244038,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dysgerminoma </span></span></span></p>"
        },
        {
          "id": 244039,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Granulosa cell tumor </span></span></span></p>"
        },
        {
          "id": 244040,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mucinous adenocarcinoma</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A patient with an adnexal mass underwent surgery, and the following tumor was removed. What is the likely diagnosis? (AIIMS NOV 2016)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/1.jpg\" style=\"height:275px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q6430143",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606857,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Mature teratoma</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The tumor described contains hair, teeth, and ovarian tissue, which are characteristic features of a benign teratoma, also known as a dermoid cyst. Benign teratomas are typically cystic and can contain various tissues such as hair, sebaceous material, and tooth structures. They are usually found in young women during their reproductive years and are often unilocular cysts with a wall lined by skin-like structures.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Dysgerminoma</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> - Dysgerminomas are usually solid tumors with a different histological appearance, characterized by large vesicular cells with clear cytoplasm and centrally placed nuclei.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>C. Granulosa cell tumor</strong> - These tumors typically present with different histological features and do not contain hair, teeth, or other differentiated tissues.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>D. Mucinous adenocarcinoma</strong> - This type of tumor is characterized by mucin-producing epithelial cells and does not typically contain hair or teeth.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mature teratomas, or dermoid cysts, are characterized by the presence of differentiated tissues such as hair, teeth, and sebaceous material, making them identifiable upon gross examination</span></span></span></p>",
      "correct_choice_id": 244037,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44010,
      "choices": [
        {
          "id": 175699,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Remove placenta and reposition the uterus</span></span></span></p>"
        },
        {
          "id": 175700,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Put uterus inside without removing the placenta</span></span></span></p>"
        },
        {
          "id": 175701,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Shift to OT and insert the uterus back</span></span></span></p>"
        },
        {
          "id": 175702,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Start Oxytocin</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient has just delivered a full-term baby and developed uterine inversion with the placenta still attached. What is the immediate next step?&nbsp;</span></span>(INICET NOV 2023)</p>",
      "unique_key": "Q3668794",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606858,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Put uterus inside without removing the placenta</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Immediate management of uterine inversion involves repositioning the uterus before removing the placenta to prevent severe bleeding and shock.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Remove placenta and reposition the uterus:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Removing the placenta before repositioning the uterus can lead to massive hemorrhage.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Shift to OT and insert the uterus back:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Immediate manual repositioning is crucial before shifting to an operating theatre.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Start Oxytocin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Oxytocin is used after the uterus is repositioned to encourage contraction, not before.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the case of uterine inversion, the uterus should be repositioned with the placenta still attached to avoid significant bleeding, followed by medical management for uterine contraction.</span></span></span></p>",
      "correct_choice_id": 175700,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9911,
      "choices": [
        {
          "id": 39610,
          "text": "<p><span style=\"font-size:12pt;\">Paget disease</span></p>"
        },
        {
          "id": 39611,
          "text": "<p><span style=\"font-size:12pt;\">Lichen Sclerosus</span></p>"
        },
        {
          "id": 39612,
          "text": "<p><span style=\"font-size:12pt;\">Lichen planus</span></p>"
        },
        {
          "id": 39613,
          "text": "<p><span style=\"font-size:12pt;\">Angioma of vulva</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the condition shown in the image below?</span>(INICET MAY 2022)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture3033-1.jpg\" alt=\"\" width=\"300\" height=\"211\"></span></p>",
      "unique_key": "Q5134905",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606859,
      "difficulty_level": "intermediate",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Lichen Sclerosus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The given image shows Lichen Sclerosus.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Lichen Sclerosus <strong>usually presents in postmenopausal women</strong>. Lichen sclerosus is one of the common dermatoses to affect the ano‐genital skin</span></li><li><span style=\"font-size:12pt;\">The presenting symptom is usually itching, which is often severe and distressing. Patients may also complain of <strong>discomfort and dyspareunia</strong> if there is introital narrowing <strong>Perianal involvement frequently manifests as a figure-8 shape</strong>.</span></li><li><span style=\"font-size:12pt;\"><strong>White, atrophic papules&nbsp;</strong>with abnormal <strong>anatomy distortion</strong> are the typical appearance. These <strong>papules</strong> may coalesce into <strong>plaques.</strong></span></li><li><span style=\"font-size:12pt;\">It is possible for introital stenosis, clitoral concealment, labia minora regression, and urethral obstruction to occur. <strong>A biopsy is required to rule out cancer</strong>.</span></li><li><span style=\"font-size:12pt;\"><strong>Topical corticosteroids remain the first line of treatment.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A</strong>. <strong>Paget</strong> <strong>Disease</strong>: Usually manifests as <strong>red</strong>, <strong>scaly</strong>, and <strong>crusty</strong> <strong>patches</strong> on the <strong>vulvar</strong> skin as shown in the image below.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture3122.jpg\" alt=\"\" width=\"252\" height=\"188\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">It is often associated with an <strong>underlying</strong> <strong>malignancy</strong>. It does <strong>not</strong> present with <strong>white</strong> <strong>atrophic</strong> <strong>papules</strong> as shown in the question.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Lichen Planus:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Presents with <strong>purplish</strong>, <strong>flat</strong>-<strong>topped</strong>, <strong>itchy</strong> <strong>papules</strong> and <strong>plaques</strong>, often with a <strong>reticular</strong> <strong>pattern</strong> on <strong>mucous</strong> <strong>membranes</strong>, <strong>not</strong> typically <strong>white</strong> <strong>atrophic</strong> <strong>papules</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Angioma of Vulva:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">This would present as a <strong>benign</strong> <strong>growth</strong> of <strong>small</strong> <strong>blood</strong> <strong>vessels</strong> and would be <strong>red</strong> and <strong>vascular</strong> in appearance as shown below.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture3222.jpg\" alt=\"\" width=\"200\" height=\"299\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational</strong> <strong>Objective</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">When encountering <strong>white</strong> <strong>atrophic</strong> <strong>papules</strong> and <strong>plaques</strong> on the <strong>vulva</strong> that may <strong>coalesce</strong> and <strong>distort</strong> the <strong>vulvar</strong> anatomy, <strong>lichen</strong> <strong>sclerosus</strong> should be considered as a primary diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Premalignant lesions of vulva:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Vulvar Intraepithelial neoplasia (VIN)</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Paget’s</strong> disease</span></li><li><span style=\"font-size:12pt;\"><strong>Lichen</strong> <strong>sclerosus</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Condyloma</strong> <strong>acuminata</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Bowen&nbsp;</strong>disease (Erythroplasia of <strong>Queyrat</strong>)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref - William’s gynecology 4<sup>th</sup> edition Page no 92-100, 688</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Shaw’s textbook of gynecology, 17<sup>th</sup> edition Page no 323, 473-475</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Online resources:&nbsp;</strong></span><a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6298145/\"><span style=\"font-size:12pt;\"><strong><u>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6298145/</u></strong></span></a></p>",
      "correct_choice_id": 39611,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13864,
      "choices": [
        {
          "id": 55417,
          "text": "<p><span style=\"font-size:12.0pt;\">Bone</span></p>"
        },
        {
          "id": 55418,
          "text": "<p><span style=\"font-size:12.0pt;\">Ligament</span></p>"
        },
        {
          "id": 55419,
          "text": "<p><span style=\"font-size:12.0pt;\">Aponeurosis</span></p>"
        },
        {
          "id": 55420,
          "text": "<p><span style=\"font-size:12.0pt;\">Elastic cartilage</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Type I collagen is not seen in? (</span>AIIMS Nov 2018)</p>",
      "unique_key": "Q8283255",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606860,
      "difficulty_level": "beginner",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Elastic cartilage</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Elastic cartilage, as the name suggests, is more elastic than other types of cartilage. This is due to the presence of elastic fibers interspersed with the cartilage cells (chondrocytes).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The primary collagen in elastic cartilage is Type II collagen, not Type I.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Additionally, the elastin present in this cartilage gives it a yellowish appearance and makes it flexible. Examples of elastic cartilage include the external ear (auricle) and the epiglottis.</span></p><p><span style=\"font-size:11pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Bone:</strong> Bone tissue primarily consists of Type I collagen. This collagen provides a framework upon which hydroxyapatite (a crystalline structure made of calcium and phosphate) can deposit, giving bones their characteristic rigidity and strength. Type I collagen provides the bone with some flexibility and tensile strength, which helps to prevent fractures.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Ligament:</strong> Ligaments, which connect bone to bone, are primarily composed of Type I collagen. This gives ligaments their tensile strength and ability to withstand pulling forces. The presence of Type I collagen in ligaments helps in maintaining joint stability.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Aponeurosis:</strong> An aponeurosis is a flat, sheet-like tendinous structure that attaches muscle to bone or other tissues. Like tendons, aponeuroses primarily contain Type I collagen. This allows aponeuroses to transmit muscular forces effectively.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>List of types of collagens in various tissues:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/08/screenshot-2023-11-08-184305.jpg\" alt=\"\" width=\"1000\" height=\"509\"></strong></span></p>",
      "correct_choice_id": 55420,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6079,
      "choices": [
        {
          "id": 24285,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cry of baby in the womb</span></span></span></p>"
        },
        {
          "id": 24286,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Infection of vagina</span></span></span></p>"
        },
        {
          "id": 24287,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Infection of uterus</span></span></span></p>"
        },
        {
          "id": 24288,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Infection of both vagina and uterus</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is vagitus uterinus?&nbsp;</span></span>(INICET NOV 2022)</p>",
      "unique_key": "Q1796532",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606881,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Cry of baby in the womb</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vagitus uterinus</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is the term used to describe the cry of a baby in the womb. It is a rare phenomenon but can occur if there is a rupture of the amniotic sac with air entry, allowing the baby to make crying sounds while still in utero.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vagitus vaginus</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is the term for the cry of the baby in the vagina, which can be heard during delivery.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Infection of the vagina</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> causes vaginitis.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Infection of the uterus</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> may affect its layers, leading to conditions such as endometritis (infection of the endometrium), myometritis (infection of the myometrium), and perimetritis (infection of the perimetrium).</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Infection of vagina</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Infection of the vagina causes vaginitis, which is not related to the term vagitus uterinus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Infection of uterus</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Infection of the uterus can lead to endometritis, myometritis, or perimetritis, which are not related to the term vagitus uterinus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Infection of both vagina and uterus</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Infection of both the vagina and uterus involves conditions such as vaginitis and endometritis/myometritis/perimetritis, which are not related to the term vagitus uterinus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vagitus uterinus refers to the cry of a baby in the womb, which is a rare phenomenon that can occur if there is a rupture of the amniotic sac with air entry.</span></span></span></p>",
      "correct_choice_id": 24285,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20819,
      "choices": [
        {
          "id": 83240,
          "text": "<p><span style=\"font-size:12.0pt;\">Left optic tract</span></p>"
        },
        {
          "id": 83241,
          "text": "<p><span style=\"font-size:12.0pt;\">Right optic tract</span></p>"
        },
        {
          "id": 83242,
          "text": "<p><span style=\"font-size:12.0pt;\">Optic chiasma</span></p>"
        },
        {
          "id": 83243,
          "text": "<p><span style=\"font-size:12.0pt;\">Optic radiation</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient has Bilateral right sided loss of vision. What is the most likely site of lesion. (NEET PG 2023)</span></p>",
      "unique_key": "Q1424813",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606882,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Left optic tract</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Given the description of \"Bilateral right sided loss of vision,\" the most likely site of the lesion would be the&nbsp;<strong> Left optic tract</strong>. This type of visual field loss is consistent with the right visual field information being interrupted after the optic chiasma, which would affect the right visual field in both eyes.The optic tracts carry visual information after it has crossed at the optic chiasma. A lesion in the left optic tract would lead to a loss of vision in the right visual field of both eyes (homonymous hemianopia). This is because the left optic tract carries information from the right half of the visual field of each eye.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Right Optic Tract</strong>: Similarly, a lesion in the right optic tract would cause a loss of vision in the left visual field of both eyes. This is also homonymous hemianopia, but on the opposite side of the visual field loss compared to a left optic tract lesion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Optic Chiasma</strong>: A lesion at the optic chiasma can cause various types of visual field defects. The most common is bitemporal hemianopia, which is the loss of the outer (temporal) halves of the visual field in both eyes. This typically occurs with pituitary tumors that compress the chiasma from below.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Optic Radiation</strong>: The optic radiation carries visual information from the thalamus to the visual cortex. A lesion in the optic radiation can also lead to homonymous hemianopia. The specific location within the optic radiation (e.g., Meyer's loop) can lead to more specific deficits like a superior quadrantanopia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Understanding the visual pathway is critical for localizing lesions based on patterns of visual field loss. Lesions at different points along the visual pathway (e.g., optic nerves, chiasma, tracts, or radiations) will produce characteristic visual field defects. This knowledge is used to guide further diagnostic testing and management, which may include imaging studies like MRI or CT scans to visualize the lesion and determine its cause.</span></p>",
      "correct_choice_id": 83240,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44862,
      "choices": [
        {
          "id": 179095,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Enoxaparin</span></span></span></p>"
        },
        {
          "id": 179096,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lepirudin</span></span></span></p>"
        },
        {
          "id": 179097,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fondaparinux</span></span></span></p>"
        },
        {
          "id": 179098,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dabigatran</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following anticoagulant requires coagulation profile monitoring? (</span></span></span>INICET May 2024)</p>",
      "unique_key": "Q9926497",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606883,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Lepirudin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lepirudin</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is a direct thrombin inhibitor that typically requires regular monitoring of anticoagulant effect via activated partial thromboplastin time (aPTT).</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Enoxaparin&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(a low molecular weight heparin), <strong>Fondaparinux</strong> (a synthetic pentasaccharide), and <strong>Dabigatran</strong> (a direct thrombin inhibitor) generally do not require regular monitoring in most patients, although there may be specific clinical situations where monitoring is needed.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 179096,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7018,
      "choices": [
        {
          "id": 28040,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Class I</span></span></span></p>"
        },
        {
          "id": 28041,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Class II</span></span></span></p>"
        },
        {
          "id": 28042,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Class III</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>"
        },
        {
          "id": 28043,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Class IV</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dofetilide belongs to which class of anti-arrhythmic drugs? (AIIMS MAY 2017)</span></span></p>",
      "unique_key": "Q7520380",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606884,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. Class III</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dofetilide is a class III anti arrhythmic drug that works by blocking K+ channels. The other class III anti arrhythmic include Amiodarone, Ibutilide, Sotalol and bretylium.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The side effect is QT prolongation/Torsades de pointes.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Class I</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: These are sodium channel blockers. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Class II</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: These are beta-blockers. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Class IV</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: These are calcium channel blockers.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Class III drugs include:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">B: Bretylium</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">I: Ibutilide</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">N</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">D: Dofetilide</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A: Amiodarone</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">S: Sotalol</span></span></span></p>",
      "correct_choice_id": 28042,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5273,
      "choices": [
        {
          "id": 21064,
          "text": "<p><span style=\"font-size:12.0pt;\">Cotrimoxazole</span></p>"
        },
        {
          "id": 21065,
          "text": "<p><span style=\"font-size:12.0pt;\">Co-amoxiclav</span></p>"
        },
        {
          "id": 21066,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspirin</span></p>"
        },
        {
          "id": 21067,
          "text": "<p><span style=\"font-size:12.0pt;\">Chloramphenicol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient comes with a history of asthma and sinusitis. On looking into his medical records, you notice this has been attributed to Samter's triad. Which drug should be avoided in this patient? (NEET PG 2022)</span></p>",
      "unique_key": "Q6264306",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606885,
      "difficulty_level": "beginner",
      "subjects_id": [
        9
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Aspirin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In a patient with Samter's triad, aspirin should be avoided as he will have aspirin intolerance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Samter's triad is also known as aspirin-induced asthma or aspirin-sensitive asthma.</strong> It consists of:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Nasal polyposis</span></li><li><span style=\"font-size:12.0pt;\">Bronchial asthma</span></li><li><span style=\"font-size:12.0pt;\">Aspirin intolerance</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Aspirin and COX – 1 inhibitors can exacerbate asthma hence they should be avoided. Rhinorrhea, conjunctival injection, facial flushing, and periorbital edema are also seen. Aspirin-induced hypersensitivity reactions also may occur.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The provocative challenge test with aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) is the only diagnostic method.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Aspirin desensitization is an important therapeutic option in patients with ST, especially in those patients suffering from recurrent NPs, anosmia, and overdependence on systemic corticosteroids</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Cotrimoxazole</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>and Option</strong> <strong>B. Co-amoxiclav</strong>: These are antibiotics used to treat bacterial infections, including sinusitis, and do not affect COX-1 activity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Chloramphenicol</strong>: An antibiotic that is generally used for serious infections where other antibiotics are not suitable. It does not interact with the COX-1 pathway.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">In patients diagnosed with Samter's triad, it is crucial to avoid aspirin and other NSAIDs that inhibit COX-1, as these can trigger severe respiratory and nasal symptoms. Effective management involves identifying safe medications for pain and inflammation and regularly monitoring the respiratory and nasal health of the patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref - Dhingra 7th edition, Page No. 193, 194</strong></span></p>",
      "correct_choice_id": 21066,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61192,
      "choices": [
        {
          "id": 244049,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hormone replacement therapy with estrogen and progesterone</span></span></span></p>"
        },
        {
          "id": 244050,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bilateral gonadectomy</span></span></span></p>"
        },
        {
          "id": 244051,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Gonadotropin therapy to induce puberty</span></span></span></p>"
        },
        {
          "id": 244052,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Regular monitoring of gonads with ultrasound</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 18-year-old girl presents to the clinic with concerns of primary amenorrhea and lack of breast development. On physical examination, she is noted to have Prader 3 genitalia, indicating significant virilization with an increased phallic size and partial labioscrotal fusion. Laboratory evaluation reveals elevated levels of Follicle-Stimulating Hormone (FSH). Further imaging with pelvic ultrasound reveals Mullerian structures, but the gonads are poorly visualized. A karyotype analysis shows 45, XO/46, XY mosaicism. Given these findings, what would be the next best step in management for this patient?</span></span></span></p>",
      "unique_key": "Q3624330",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606886,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans.&nbsp; B. Bilateral gonadectomy</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The patient has gonadal dysgenesis with virilization, characterized by the presence of a Y chromosome and dysgenetic gonads. This condition carries a high risk of malignancy, including gonadoblastoma or dysgerminoma, due to the presence of Y chromosome material in the dysgenetic gonads. Bilateral gonadectomy is recommended to remove these gonads prophylactically at the time of diagnosis to prevent malignancy. The removal of gonads eliminates the risk of cancer and also addresses any androgen production that may contribute to virilization.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Hormone replacement therapy with estrogen and progesterone:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is an important step in managing this patient&rsquo;s condition, but it should only be initiated after the gonads are removed. Estrogen therapy is necessary for the development of secondary sexual characteristics and bone health but does not mitigate the cancer risk posed by dysgenetic gonads.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Gonadotropin therapy to induce puberty:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is not appropriate because the primary concern in this patient is the high risk of malignancy associated with her gonads. Gonadotropin therapy will not address the underlying risk and is not used in cases of gonadal dysgenesis with a Y chromosome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Regular monitoring of gonads with ultrasound:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Ultrasound monitoring is insufficient in this context because it does not reliably detect early malignant transformation in dysgenetic gonads. Prophylactic removal is the safest course of action to prevent potential malignancies.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In patients with gonadal dysgenesis and a Y chromosome, such as those with 45,X0/46,XY mosaicism, bilateral gonadectomy is crucial to eliminate the significant risk of malignancy. Prophylactic removal of dysgenetic gonads is prioritized to prevent cancer, followed by hormone replacement therapy to manage pubertal development and long-term health.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/3.jpeg\" style=\"height:899px; width:975px\" /></span></span></span></p>",
      "correct_choice_id": 244050,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24739,
      "choices": [
        {
          "id": 98917,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Stagnant hypoxia</span></span></span></p>"
        },
        {
          "id": 98918,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Histotoxic hypoxia</span></span></span></p>"
        },
        {
          "id": 98919,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hypoxic hypoxia</span></span></span></p>"
        },
        {
          "id": 98920,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Anemic hypoxia</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the type of hypoxia according to given graph: (Brown graph is normal)</span></span> <span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">INICET MAY 2023)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/12/whatsapp-image-2023-07-04-at-125697.jpg\" style=\"height:335px; width:400px\" /></span></span></p>",
      "unique_key": "Q4485811",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606887,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Anemic hypoxia</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The given graph illustrates a 50% reduction in the oxygen saturation of hemoglobin, even though the partial pressure of oxygen (PO2) stays within the expected range. This state is termed anemic hypoxia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anemic hypoxia occurs when there is a reduction in the oxygen-carrying capacity of the blood, usually due to a lower amount of hemoglobin, as seen in anemia. Despite normal levels of PO2, the overall oxygen content in the blood is diminished, leading to insufficient oxygen delivery to tissues.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A. Stagnant hypoxia</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This occurs when oxygen deficiency is due to poor blood circulation, not a reduced oxygen-carrying capacity of the blood. It is caused by issues like arterial obstruction or ischemia. The graph for stagnant hypoxia would show normal oxygen content in arterial blood but lower content in venous blood due to poor perfusion.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">B. Histotoxic hypoxia</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: In this type, the cells are unable to utilize oxygen effectively, even though it is adequately supplied by the blood. This condition is typically caused by toxins like cyanide that impair cellular respiration. The graph for histotoxic hypoxia would show normal oxygen content in both arterial and venous blood since the issue is within the cells&#39; ability to use oxygen, not the blood&#39;s ability to transport it.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">C. Hypoxic hypoxia</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This occurs when there is a generalized lack of oxygen in the body&#39;s tissues due to low oxygen in the blood, often seen at high altitudes or in conditions like COPD. The graph would show reduced PO2 along with decreased oxygen content in both arterial and venous blood.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol style=\"list-style-type:upper-alpha\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Stagnant hypoxia: Oxygen deficiency due to poor blood circulation.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Histotoxic hypoxia: Cells unable to utilize oxygen despite its availability.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hypoxic hypoxia: Generalized lack of oxygen in the body&#39;s tissues.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Anemic hypoxia: Reduced oxygen-carrying capacity of blood due to low hemoglobin.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/12/whatsapp-image-2023-07-04-at-125698.jpg\" style=\"height:200px; width:700px\" /></span></span></span></p>",
      "correct_choice_id": 98920,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5803,
      "choices": [
        {
          "id": 23183,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Simple hysterectomy</span></span></span></p>"
        },
        {
          "id": 23184,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Medroxy progesterone acetate</span></span></span></p>"
        },
        {
          "id": 23185,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Levonorgestrel</span></span></span></p>"
        },
        {
          "id": 23186,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Radiotherapy</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which among the following is an ideal treatment for a 55-year-old female with simple hyperplasia of the endometrium with atypia?&nbsp;</span></span>(INICET MAY 2018)</p>",
      "unique_key": "Q6425734",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606888,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Simple hysterectomy</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For postmenopausal women with atypical hyperplasia of the endometrium, the recommended treatment is a total hysterectomy. This approach is taken due to the increased risk of progression to endometrial carcinoma, especially given the presence of atypia and the patient&#39;s postmenopausal status.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Simple Hysterectomy:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This involves the surgical removal of the uterus and is considered the ideal treatment for postmenopausal women with endometrial hyperplasia with atypia to prevent the progression to cancer.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Medroxyprogesterone acetate:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is a progestogen treatment used primarily for managing endometrial hyperplasia without atypia, especially in women who desire to preserve fertility. It is not the ideal treatment for atypical hyperplasia in a postmenopausal woman.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Levonorgestrel:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The Levonorgestrel intrauterine system (LNG-IUS) is used for managing endometrial hyperplasia without atypia and as a conservative treatment for women wishing to preserve fertility. However, it is not the treatment of choice for atypical hyperplasia in a postmenopausal woman.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Radiotherapy:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is not a standard treatment for endometrial hyperplasia with atypia. It is typically reserved for more advanced or inoperable endometrial cancers.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For postmenopausal women with endometrial hyperplasia with atypia, the ideal treatment is a total hysterectomy to prevent progression to endometrial carcinoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 330, DC Dutta&rsquo;s Textbook of Obstetrics 8<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23183,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44021,
      "choices": [
        {
          "id": 175743,
          "text": "<p><span style=\"font-size:12pt;\">Rashes</span></p>"
        },
        {
          "id": 175744,
          "text": "<p><span style=\"font-size:12pt;\">Hyponatremia</span></p>"
        },
        {
          "id": 175745,
          "text": "<p><span style=\"font-size:12pt;\">Blood dyscrasias</span></p>"
        },
        {
          "id": 175746,
          "text": "<p><span style=\"font-size:12pt;\">Hepatitis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following side effects are more commonly seen with carbamezapine than oxcarbazepine , except ?&nbsp;</span>&nbsp;(INICET NOVEMBER 2023)</p>",
      "unique_key": "Q5871755",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606889,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Hyponatremia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Hyponatremia is more commonly associated with oxcarbazepine than carbamazepine. Oxcarbazepine induces this through its effect on renal handling of water by affecting antidiuretic hormone.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Rashes: </strong>Rashes are more common with carbamazepine due to its propensity to cause allergic skin reactions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Blood dyscrasias:</strong> Blood dyscrasias, including agranulocytosis and aplastic anemia, are more associated with carbamazepine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Hepatitis:</strong> Hepatitis and other liver dysfunctions are more often linked to carbamazepine than oxcarbazepine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">While both carbamazepine and oxcarbazepine can cause similar side effects, hyponatremia is notably more prevalent with oxcarbazepine.</span></p>",
      "correct_choice_id": 175744,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5887,
      "choices": [
        {
          "id": 23518,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nulliparous, singleton, cephalic, induced labour</span></span></span></p>"
        },
        {
          "id": 23519,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nulliparous, singleton, cephalic, spontaneous labour</span></span></span></p>"
        },
        {
          "id": 23520,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Multiparous without previous CS, spontaneous labour</span></span></span></p>"
        },
        {
          "id": 23521,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Multiparous without previous CS, induced/CS before labour</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Modified Robson&#39;s classification class 1 includes:&nbsp;</span></span></span>(INICET MAY 2020)</p>",
      "unique_key": "Q8673487",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606890,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Nulliparous, singleton, cephalic, spontaneous labour</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Class 1 of the Modified Robson&#39;s classification specifically includes:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nulliparous</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: A woman who has never given birth before.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Singleton</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: A pregnancy involving only one fetus.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cephalic</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The fetal presentation is head-down.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&ge;37 weeks</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The pregnancy is at or beyond 37 weeks of gestation.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Spontaneous labour</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Labour onset is spontaneous, not induced or via cesarean section.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This classification is used to categorize pregnant women for analyzing obstetric outcomes, interventions, and cesarean section rates. The Modified Robson&rsquo;s classification is a system developed by the World Health Organization to help in understanding and comparing cesarean section rates and labor outcomes across different settings.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/26/untitled-227.jpg\" style=\"height:570px; width:900px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Robson&rsquo;s 10 groups</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Nulliparous, singleton, cephalic, induced labour</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This option describes Class 2 of the Modified Robson&#39;s classification, which includes nulliparous women with a singleton cephalic fetus who are &ge;37 weeks and have induced labor or a cesarean section before labor.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Multiparous without previous CS, spontaneous labour</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This option describes Class 3 of the Modified Robson&#39;s classification, which includes multiparous women (without previous cesarean section) with a singleton cephalic fetus who are &ge;37 weeks and are in spontaneous labor.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Multiparous without previous CS, induced/CS before labour</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This option describes Class 4 of the Modified Robson&#39;s classification, which includes multiparous women (without previous cesarean section) with a singleton cephalic fetus who are &ge;37 weeks and have induced labor or a cesarean section before labor.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Class 1 of the Modified Robson&#39;s classification includes nulliparous women with a singleton cephalic fetus who are &ge;37 weeks and are in spontaneous labor.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><a href=\"https://iris.who.int/bitstream/handle/10665/259512/9789241513197-eng.pdf?sequence=1\" style=\"color:#0563c1; text-decoration:underline\"><strong>https://iris.who.int/bitstream/handle/10665/259512/9789241513197-eng.pdf?sequence=1</strong></a></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>",
      "correct_choice_id": 23519,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13927,
      "choices": [
        {
          "id": 55669,
          "text": "<p><span style=\"font-size:12.0pt;\">Ex-Press™ implant</span></p>"
        },
        {
          "id": 55670,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Ahmed glaucoma valve﻿﻿﻿</span></p>"
        },
        {
          "id": 55671,
          "text": "<p><span style=\"font-size:12.0pt;\">Molteno implant</span></p>"
        },
        {
          "id": 55672,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Baerveldt implant</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 50-year-old male presented with progressive blurred vision, photophobia, and eye pain. On examination, there was conjunctival redness, a mid-dilated pupil, and a shallow anterior chamber in the right eye. He has been treated both medically and surgically for the condition but showed no improvement. The following procedure incorporates a device to aid drainage. Identify the device.&nbsp;</span>&nbsp;(NEET PG 2019)</p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/untitled-128.jpg\" alt=\"\" width=\"400\" height=\"248\"></span></p>",
      "unique_key": "Q8633568",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606891,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Ex-Press™ implant</strong></span></p><p style=\"margin-left:24px;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical vignette points to a diagnosis of glaucoma not responsive to medical treatment and trabeculectomy and the device used is Ex-Press™ glaucoma implant (mini shunt).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">It is a minimally invasive glaucoma surgery (MIGS) to increase aqueous drainage.</span></p><ul><li><span style=\"font-size:12.0pt;\">A tiny stainless-steel implant called Ex-PRESS is used to treat glaucoma.</span></li><li><span style=\"font-size:12.0pt;\">It is implanted during a modified trabeculectomy underneath a scleral flap.</span></li><li><span style=\"font-size:12.0pt;\">Hypotony-related complications are less common than with conventional trabeculectomy.</span></li><li><span style=\"font-size:12.0pt;\">By creating a communication between the anterior chamber and the sub-space/sub-conjunctival Tennon's space, glaucoma drainage devices enable aqueous outflow.</span></li><li><span style=\"font-size:12.0pt;\">While formerly only used in high-risk patients or after a failed trabulectomy, these devices are gaining popularity.</span></li><li><span style=\"font-size:12.0pt;\">The commonly used devices are as follows:</span><ul><li><span style=\"font-size:12.0pt;\">﻿﻿Shunts using episcleral explants</span></li><li><span style=\"font-size:12.0pt;\">﻿﻿Ahmed glaucoma valve- Silicone</span></li><li><span style=\"font-size:12.0pt;\">﻿﻿Molteno implant- Polypropelene plate and silicone plate</span></li><li><span style=\"font-size:12.0pt;\">﻿﻿Baerveldt implant- Silicone</span></li><li><span style=\"font-size:12.0pt;\">﻿﻿Mini-shunts</span></li><li><span style=\"font-size:12.0pt;\">﻿﻿Ex-Press™M Mini-Shunt- Stainless steel</span></li><li><span style=\"font-size:12.0pt;\">﻿﻿iStent®- Titanium</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Ahmed Glaucoma Valve:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\">Made of silicone.</span></li><li><span style=\"font-size:12.0pt;\">Contains a valve mechanism to prevent hypotony.</span></li><li><span style=\"font-size:12.0pt;\">Popular for its ease of implantation and reliable outcomes.</span></li><li><span style=\"font-size:12.0pt;\">Used in cases requiring controlled aqueous humor outflow but differs in design and function from the Ex-Press™ implant</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Molteno Implant:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\">Made of polypropylene plate and silicone plate.</span></li><li><span style=\"font-size:12.0pt;\">One of the earliest glaucoma drainage devices, offering various plate sizes.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Baerveldt Implant:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\">Made of silicone.</span></li><li><span style=\"font-size:12.0pt;\">Designed to provide large surface area for filtration.</span></li><li><span style=\"font-size:12.0pt;\">Requires ligation to prevent early postoperative hypotony.</span></li><li><span style=\"font-size:12.0pt;\">Also used for glaucoma management</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/0007%20(2).png\" width=\"975\" height=\"624\"></p><p>&nbsp;</p><p><span style=\"background-color:transparent;color:#000000;font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/0007%20(1).png\" width=\"975\" height=\"826\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Ex-Press™ glaucoma implant is a minimally invasive device used during modified trabeculectomy to enhance aqueous drainage and reduce intraocular pressure in patients with glaucoma. This implant is characterized by its stainless-steel construction and effectiveness in controlling glaucoma with fewer hypotony-related complications.</span></p>",
      "correct_choice_id": 55669,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "InstrumentsBased",
        "OlderNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61191,
      "choices": [
        {
          "id": 244045,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Polycystic kidney disease</span></span></span></p>"
        },
        {
          "id": 244046,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cystic fibrosis</span></span></span></p>"
        },
        {
          "id": 244047,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Young syndrome</span></span></span></p>"
        },
        {
          "id": 244048,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Androgen insensitivity syndrome</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 28-year-old man presents to a fertility clinic with his spouse after 12 months of unprotected intercourse without any conception. He denies any history of erectile dysfunction or sexually transmitted infections. His medical history is unremarkable, and he has not undergone any surgeries. A semen analysis reveals azoospermia. A scrotal ultrasound shows the absence of bilateral vas deferens. The patient has no history of lung disease or gastrointestinal symptoms. The congenital absence of seminal vesicles and vas deferens is most commonly associated with which of the following conditions?</span></span></span></p>",
      "unique_key": "Q8982697",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606892,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. Cystic fibrosis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The congenital absence of the seminal vesicles and vas deferens, referred to as <strong>congenital bilateral absence of the vas deferens (CBAVD)</strong>, is most commonly associated with <strong>cystic fibrosis (CF)</strong>. CF is an autosomal recessive disorder caused by mutations in the <strong>CFTR gene</strong> that impair the function of chloride channels. In men with cystic fibrosis, the absence of the vas deferens and seminal vesicles leads to <strong>obstructive azoospermia</strong>, where sperm are produced but cannot be transported out due to this obstruction. Some men with CBAVD may have few or no respiratory or gastrointestinal symptoms, making infertility their primary or only presenting issue.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pathophysiology:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> In CF, the absence of the vas deferens occurs due to abnormal CFTR gene function affecting the development of the male reproductive tract. As a result, the vas deferens fails to develop or is nonfunctional, leading to obstructive infertility.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Clinical Presentation:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Men with CF and CBAVD often present with infertility without the characteristic respiratory or digestive issues commonly associated with CF.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Polycystic kidney disease:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This genetic disorder is characterized by the growth of numerous cysts in the kidneys, leading to kidney failure over time. It does not affect the male reproductive system, and the vas deferens and seminal vesicles are typically present, making this an incorrect answer.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Young syndrome:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Young syndrome is a condition associated with chronic sinusitis, bronchiectasis, and obstructive azoospermia. While it does cause obstructive azoospermia, the vas deferens are typically present but blocked with thick mucus, unlike in cystic fibrosis where the vas deferens are congenitally absent.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Androgen insensitivity syndrome:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> In this condition, individuals with a 46,XY karyotype are phenotypically female due to resistance to androgens. These individuals have undescended testes and lack a uterus, but their reproductive tract does not develop normally. The absence of the vas deferens is not seen in this syndrome, making it an unlikely cause of the patient&rsquo;s infertility.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cystic fibrosis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> is associated with <strong>congenital bilateral absence of the vas deferens (CBAVD)</strong>, a condition that leads to obstructive azoospermia and infertility in males. CBAVD may occur as an isolated feature of cystic fibrosis without the classical pulmonary or gastrointestinal manifestations of the disease.</span></span></span></p>",
      "correct_choice_id": 244046,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10075,
      "choices": [
        {
          "id": 40266,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Rett syndrome</span></span></span></p>"
        },
        {
          "id": 40267,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Duchenne muscular dystrophy</span></span></span></p>"
        },
        {
          "id": 40268,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Huntington disease</span></span></span></p>"
        },
        {
          "id": 40269,
          "text": "<p style=\"margin-right:-64px; text-align:left\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tuberous sclerosis</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Identify the disorder with X-linked dominant inheritance:</span> <span style=\"font-size:12.0pt\">(INICET MAY 2022)</span></span></span></p>",
      "unique_key": "Q3687189",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606893,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Rett syndrome</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rett syndrome is inherited in an X-linked dominant pattern.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rett syndrome:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:-64px; text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-64px; text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/screenshot-2023-11-10-125144.jpg\" style=\"height:402px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:-64px; text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other examples of XLD disorders include Vitamin D Independent Rickets, Aicardi Syndrome, Hypophosphatemic Rickets, Incontinentia pigmenti.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Duchenne muscular dystrophy (DMD)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Duchenne muscular dystrophy (DMD) is inherited in X linked recessive pattern. </span><span style=\"font-size:12.0pt\">It is caused by mutations in the dystrophin gene and predominantly affects boys, leading to progressive muscle weakness and wasting.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Huntington&#39;s disease</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Huntington&#39;s disease is inherited in an autosomal dominant pattern. </span><span style=\"font-size:12.0pt\">It is characterized by progressive neurodegeneration, leading to motor dysfunction, cognitive decline, and psychiatric symptoms.</span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Tuberous sclerosis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Tuberous sclerosis / Bournville disease is inherited in an autosomal dominant pattern, </span><span style=\"font-size:12.0pt\">characterized by the development of benign tumors in multiple organs.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rett syndrome is an X-linked dominant disorder most commonly seen in girls, characterized by microcephaly, regression of motor milestones, developmental delay, and stereotyped movements.</span></span></span></p>",
      "correct_choice_id": 40266,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11705,
      "choices": [
        {
          "id": 46786,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thiamine </span></span></span></span></p>"
        },
        {
          "id": 46787,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pyridoxine</span></span></span></span></p>"
        },
        {
          "id": 46788,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Folic acid </span></span></span></span></p>"
        },
        {
          "id": 46789,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Methylcobalamine</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient on anti-tubercular therapy develops tingling sensation in the limbs. Which of the following when substituted can result from in improvement of symptoms? (AIIMS NOV 2018)</span></span></span></span></p>",
      "unique_key": "Q1570779",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606894,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Pyridoxine</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is a case of peripheral neuropathy that occurs in ATT therapy due to isoniazid (INH)</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">To treat this &ndash; Pyridoxine 10-25mg/day should be added to regimen.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">High risk patients for peripheral neuropathy include- malnutrition, chronic alcohol dependence, diabetes, HIV.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Thiamine:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While important for nervous system function, thiamine is not typically depleted by INH therapy.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Folic acid:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Not directly related to the neurological side effects of INH.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Methylcobalamin:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Though important for nerve health, it is not the primary vitamin depleted by INH therapy.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pyridoxine (vitamin B6) supplementation is essential for patients receiving isoniazid as part of their anti-tubercular therapy to prevent or manage peripheral neuropathy symptoms.</span></span></span></span></p>",
      "correct_choice_id": 46787,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10031,
      "choices": [
        {
          "id": 40090,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1-D; 2-A; 3-C; 4-B</span></span></span></p>"
        },
        {
          "id": 40091,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1-C; 2-A; 3-B; 4-D</span></span></span></p>"
        },
        {
          "id": 40092,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1-C; 2-B; 3-D; 4-A</span></span></span></p>"
        },
        {
          "id": 40093,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1-D; 2-A; 3-B; 4-C</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Match the following Interleukins with their effector cells? (INICET NOV 2022)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-130732.jpg\" style=\"height:339px; width:600px\" /></span></span></p>",
      "unique_key": "Q5139238",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606895,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>B) 1-C; 2-A; 3-B; 4-D </strong>&nbsp;</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Interleukins are a group of cytokines that play an essential role in immune responses by acting on different immune cells. Each type of interleukin can influence different target cells in specific ways.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">IL-4</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> - <strong>B cells</strong>: IL-4 is primarily involved in the activation and differentiation of B cells. It promotes the class switch to IgE production and plays a role in the TH2 immune response.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">IL-5</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> - <strong>Eosinophils</strong>: IL-5 is crucial for the growth and differentiation of eosinophils. It is involved in the pathogenesis of allergic diseases like asthma.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">IL-9</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> - <strong>Mast cells</strong>: IL-9 is involved in the proliferation of mast cells and enhances their function. It plays a role in allergic responses and asthma.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">IL-13</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> - <strong>Dendritic cells</strong>: IL-13 has multiple functions, including the modulation of dendritic cells, which are key antigen-presenting cells in the immune system. IL-13 also plays a significant role in allergic inflammation.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/picture8.jpg\" style=\"height:251px; width:600px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-131323.jpg\" style=\"height:841px; width:1000px\" /></span></span></span></p>",
      "correct_choice_id": 40091,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 32292,
      "choices": [
        {
          "id": 129026,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SGLT-1</span></span></span></span></p>"
        },
        {
          "id": 129027,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SGLT-2</span></span></span></span></p>"
        },
        {
          "id": 129028,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">GLUT-4</span></span></span></span></p>"
        },
        {
          "id": 129029,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">GLUT-2</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A child is presented with multiple times loose stools. He is managed with ORS. Glucose in ORS is absorbed via which transporter in GIT?(NEET PG 2021)</span></span></span></span></p>",
      "unique_key": "Q8139329",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606896,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) SGLT-1</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sodium-Glucose Transporter 1</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SGLT-1 is a transporter protein located in the small intestine. It plays a crucial role in the absorption of glucose and sodium from the gut lumen into the enterocytes (intestinal cells). In the context of ORS, SGLT-1 facilitates the absorption of glucose, which helps in the rehydration process by increasing fluid absorption.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucose and galactose are absorbed from intestinal lumen into intestinal cell via secondary active transport using sodium dependent glucose transporter (SGLT-1). On the other hand, the glucose from the intestine cell in to blood at basolateral membrane is transported via passive transporter GLUT-2 (see fig)</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/picture9.jpg\" style=\"height:341px; width:500px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. SGLT-2 (Sodium-Glucose Transporter 2)</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:&nbsp;</span></span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SGLT-2 is primarily found in the proximal renal tubules of the kidney and is responsible for the reabsorption of glucose from the urine. It is not involved in the absorption of glucose from the gastrointestinal tract.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. GLUT-4 (Glucose Transporter 4)</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:&nbsp;</span></span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">GLUT-4 is a glucose transporter primarily found in muscle and adipose tissue. It is responsible for insulin-mediated glucose uptake into these tissues and is not related to glucose absorption in the gut.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. GLUT-2 (Glucose Transporter 2)</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:&nbsp;</span></span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">GLUT-2 is a glucose transporter found in the liver, pancreatic beta cells, and the basolateral membrane of enterocytes. It is involved in glucose uptake by the liver and pancreas and is not the primary transporter for glucose absorption in the gut.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SGLT-1 is the key transporter responsible for the absorption of glucose in the gastrointestinal tract. This mechanism is crucial in the management of conditions like diarrhea, where ORS containing glucose can help rehydrate the body by enhancing fluid absorption.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">-Harper 31<sup>st</sup> e/pg. 538</span></span></strong></span></span></p>",
      "correct_choice_id": 129026,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14044,
      "choices": [
        {
          "id": 56137,
          "text": "<p><span style=\"font-size:12.0pt;\">Primary repair with end-to-end anastomosis</span></p>"
        },
        {
          "id": 56138,
          "text": "<p><span style=\"font-size:12.0pt;\">Repair with great saphenous vein graft</span></p>"
        },
        {
          "id": 56139,
          "text": "<p><span style=\"font-size:12.0pt;\">Repair with prosthetic graft</span></p>"
        },
        {
          "id": 56140,
          "text": "<p><span style=\"font-size:12.0pt;\">Repair with saphenous vein patch</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 32-year-old female patient arrives at the emergency department with a history of stabbing injury to her arm. Upon examination, there is a noticeable hematoma, and the patient reports not feeling any radial or ulnar pulses in the affected arm. Imaging reveals a 3cm longitudinal tear in the brachial artery. The medical team is faced with deciding the best treatment option for the patient. Which option should they choose? (INICET MAY 2021)</span></p>",
      "unique_key": "Q2507193",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606897,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Repair with great saphenous vein graft</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The preferred treatment option for a patient with an injury to the brachial artery caused by a stab injury is to repair it with a great saphenous vein graft harvested from the patient's uninjured leg.</span></li><li><span style=\"font-size:12.0pt;\">Repairing vessel injuries requires a tension-free approach.</span></li><li><span style=\"font-size:12.0pt;\">The great saphenous vein is the most desirable graft for interposition grafts because of its elastic properties, similar diameter to that of an extremity artery, lack of thrombogenicity, and long-term patency.</span></li><li><span style=\"font-size:12.0pt;\">Other graft materials that can be used include the cephalic vein, lesser saphenous vein, and prosthetic conduits.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Primary repair with end-to-end anastomosis</strong>: Primary arterial repair with end-to-end anastomosis is only possible if the repair can be performed in a tension-free manner. If the injured area is too long, an interposition graft is required.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Repair with prosthetic graft</strong>: Prosthetic grafts are only preferred when the native saphenous vein has been traumatized or when there is a size mismatch. Polytetrafluoroethylene (PTFE) graft is commonly used as a prosthetic conduit.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Repair with saphenous vein patch</strong>: Saphenous vein patch is used for the closure of arteriotomy site during carotid endarterectomies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Repair with a great saphenous vein graft is an appropriate choice in cases of brachial artery injury with extensive damage and vascular compromise, allowing for the restoration of blood flow to the arm. This surgical intervention should be performed urgently to prevent further ischemic complications in the affected limb.</span></p>",
      "correct_choice_id": 56138,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3439,
      "choices": [
        {
          "id": 13735,
          "text": "<p><span style=\"font-size:12.0pt;\">Crystal violet, iodine, acid alcohol, carbol fuchsin</span></p>"
        },
        {
          "id": 13736,
          "text": "<p><span style=\"font-size:12.0pt;\">Methanol, Kinyoun's carbol fuchsin, acid alcohol, methylene blue</span></p>"
        },
        {
          "id": 13737,
          "text": "<p><span style=\"font-size:12.0pt;\">Methanol, dilute carbol fuchsin, acid alcohol, crystal violet</span></p>"
        },
        {
          "id": 13738,
          "text": "<p><span style=\"font-size:12.0pt;\">Methylene blue, iodine, acid alcohol, carbol fuchsin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A HIV patient with fever, chronic diarrhea presented to OPD. His stool was examined which showed the following oocysts. Identify the components used for staining the stool? (INICET MAY 2019)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/30/untitled-250.jpg\" alt=\"\" width=\"297\" height=\"170\"></span></p>",
      "unique_key": "Q5166816",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606898,
      "difficulty_level": "beginner",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Methanol, Kinyoun's carbol fuchsin, acid alcohol, methylene blue</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Diarrhea in an HIV patient is suggestive of a coccidian parasitic infestation. The image shows a blue background and red-stained oocysts, suggestive of modified acid-fast stain positive Cryptosporidium parvum.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Modified Ziehl-Neelsen stain (mZN stain) is a type of differential bacteriological stain used to identify acid-fast organisms, mainly Mycobacteria. Acid fast organisms are those which are capable of retaining the primary stain when treated with an acid fast (holding capacity).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Members of the Actinomycetes, genus Nocardia (N. brasiliensis and N. asteroides are opportunistic pathogens) are partially acid-fast. Oocysts of coccidian parasites, such as Cryptosporidium and Isospora, are also acid-fast. Hence, they can also be detected and identified through mZN staining procedure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The reagents used for modified Ziehl–Neelsen staining are <strong>absolute methanol (for fixation), kinyoun’s carbol fuchsin (primary stain), acid alcohol (for decolorization), and methylene blue (counter stain).</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Unlike the ZN-stain, the modified ZN stain does not require heating of the reagents. Kinyoun’s carbol fuschin has greater concentration of phenol and basic fuschin and does not require heating to stain properly. <strong>Heat </strong>is used as mordant (A mordant is a substance that increases the affinity of the cell wall for a stain by binding to the primary stain, thus forming an insoluble complex, which gets trapped in the cell wall). Acid-fast bacilli are bright red after staining.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Crystal violet, iodine, acid alcohol, carbol fuchsin:</strong> This combination is not used for modified acid-fast staining but is related to Gram staining.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Methanol, dilute carbol fuchsin, acid alcohol, crystal violet:</strong> This is incorrect as the proper primary stain for the modified Ziehl-Neelsen stain is Kinyoun’s carbol fuchsin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Methylene blue, iodine, acid alcohol, carbol fuchsin:</strong> This combination is incorrect for modified Ziehl-Neelsen staining.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The modified Ziehl-Neelsen stain uses methanol for fixation, Kinyoun’s carbol fuchsin as the primary stain, acid alcohol for decolorization, and methylene blue as the counterstain to detect acid-fast organisms like Cryptosporidium parvum.</span></p>",
      "correct_choice_id": 13736,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "ImageBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5991,
      "choices": [
        {
          "id": 23934,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Concealed sex</span></span></span></p>"
        },
        {
          "id": 23935,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">True hermaphroditism</span></span></span></p>"
        },
        {
          "id": 23936,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Female pseudohermaphrodite</span></span></span></p>"
        },
        {
          "id": 23937,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Male pseudohermaphrodite</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An 18-year-old girl presented with amenorrhea. On examination, she had normal genitalia &amp; normal breast development. Her tests reveal a 5 alpha-reductase deficiency. What could be the probable diagnosis?&nbsp;</span></span>&nbsp;(INICET NOV 2021)</p>",
      "unique_key": "Q6489656",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606899,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Male pseudohermaphrodite</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The clinical vignette is suggestive of male pseudohermaphroditism.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In pseudohermaphroditism, the sex glands are of one sex while the external genitalia are of the opposite sex.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Male pseudohermaphroditism</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (male intersex) is an association of male gonads with female external genitalia.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In 5 alpha-reductase deficiency, there is a failure of the testis to descend to the scrotum and ill development of the penis, thereby resulting in the female phenotype.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Concealed sex:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Criminals may conceal their sex to avoid detection by changing dress or by other methods. This is not relevant to the clinical scenario presented.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. True hermaphroditism:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> In this condition, the glands of both sexes must be present in the same individual. Such cases are very rare. In most cases, the accessory sex gland is atrophic and lacks functional activity.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Female pseudohermaphrodite:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The fault is at the level of an enzyme block of 17-hydroxyprogesterone (21 hydroxylase deficiency is the most common cause) leading to defective production of sex steroids. There are features of virilization (clitoromegaly and the fused labioscrotal folds resemble a rudimentary scrotum). The ovaries may descend within the inguinal canal to lie in the labia majora simulating an inguinal testis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Male pseudohermaphroditism involves male gonads with female external genitalia. In 5 alpha-reductase deficiency, there is a failure of the testis to descend and ill development of the penis, resulting in a female phenotype despite having male internal genitalia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Dutta&rsquo;s textbook of gynecology&nbsp; 6<sup>th</sup> edition pg 443</span></strong><strong>&nbsp;&nbsp;&nbsp;&nbsp; </strong></span></span></p>",
      "correct_choice_id": 23937,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13877,
      "choices": [
        {
          "id": 55469,
          "text": "<p><span style=\"font-size:12.0pt;\">Right coronary artery</span></p>"
        },
        {
          "id": 55470,
          "text": "<p><span style=\"font-size:12.0pt;\">Anterior interventricular artery</span></p>"
        },
        {
          "id": 55471,
          "text": "<p><span style=\"font-size:12.0pt;\">Marginal artery</span></p>"
        },
        {
          "id": 55472,
          "text": "<p><span style=\"font-size:12.0pt;\">Diagonal artery</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following supply the structure marked ‘E’ except? (</span>AIIMS Nov 2019)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/21.jpg\" alt=\"\" width=\"300\" height=\"199\"></span></p>",
      "unique_key": "Q8355074",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606900,
      "difficulty_level": "intermediate",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Diagonal artery</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The right ventricle is the marked object. The diagonal arterial supply does not reach it.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The anterior interventricular artery, which supplies the left ventricle, has a branch called the diagonal artery. Between 30 to 50 percent of the population has this.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The right coronary artery and its branches, including the marginal artery, provide the right ventricle with the majority of its blood.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">One or two anterior right ventricular branches emerge from the anterior interventricular artery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-84.jpg\" alt=\"\" width=\"500\" height=\"446\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Right coronary artery: </strong>This is correct in terms of not being an exception. The right coronary artery primarily supplies the right atrium and the right ventricle, including the structure marked as 'E', which is the right ventricle.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Anterior interventricular artery:</strong> This artery primarily supplies the interventricular septum and the anterior walls of both ventricles. Although it predominantly serves the left ventricle, it also sends branches such as the anterior right ventricular branches that can reach the right ventricle.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Marginal artery:</strong> This artery, a branch of the right coronary artery, specifically supplies the right ventricle, which is the structure marked as 'E'.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Understanding the vascular supply of the heart is crucial, especially in clinical settings dealing with coronary artery disease. The right ventricle is primarily supplied by the right coronary artery and its branches, including the marginal artery. The diagonal artery, a branch of the left coronary system (specifically the anterior interventricular artery), mainly supplies the left ventricle and does not contribute significantly to the blood supply of the right ventricle.</span></p>",
      "correct_choice_id": 55472,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14124,
      "choices": [
        {
          "id": 56457,
          "text": "<p><span style=\"font-size:12.0pt;\">USG abdomen</span></p>"
        },
        {
          "id": 56458,
          "text": "<p><span style=\"font-size:12.0pt;\">IV fluids</span></p>"
        },
        {
          "id": 56459,
          "text": "<p><span style=\"font-size:12.0pt;\">Exploratory laparotomy</span></p>"
        },
        {
          "id": 56460,
          "text": "<p><span style=\"font-size:12.0pt;\">Elective surgery</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A man in his 50s comes to the emergency room with severe abdominal pain. During the examination, his heart rate is 120 beats per minute, and his blood pressure is measured at 90/50mmg. Guarding is observed during a per abdomen examination. An erect abdominal X-ray is provided. What is the best management in this case based on these findings? (AIIMS NOV 2020)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/04/untitled-190.jpg\" alt=\"\" width=\"300\" height=\"332\"></span></p>",
      "unique_key": "Q6510713",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606901,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Exploratory laparotomy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Given clinical scenario of tachycardia, hypotension with abdominal guarding and X ray showing pneumoperitoneum is suggestive of hollow viscous perforation. The best management would be laparotomy and repair. The next step would be IV fluids.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Given the patient's severe abdominal pain, guarding during the physical examination, tachycardia, and hypotension, along with X ray findings suggest a perforation. An exploratory laparotomy would allow for direct visualization and treatment of the underlying cause. In emergent situations like this, a surgical exploration might be the most appropriate next step. Hence, OPTION C is the most appropriate choice among the given options.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. USG abdomen:&nbsp;</strong>Ultrasonography (USG) of the abdomen is a non-invasive imaging technique used to visualize abdominal organs. It may be used for a preliminary assessment of abdominal pain, but in the case of a patient with severe pain, hemodynamic instability (as indicated by tachycardia and hypotension), and guarding, accompanied by X ray showing free air, a USG would not add to the management.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. IV fluids</strong>: Administering IV fluids can help stabilize the patient's blood pressure and is an essential immediate measure. However, fluids alone might not address the underlying cause of perforation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Elective surgery</strong>: Elective surgery is a planned procedure that is done when a condition is not immediately life-threatening. Given the severity of the patient's symptoms and the potential for an acute abdominal catastrophe, waiting for an elective procedure is not appropriate in this situation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Pneumoperitoneum&nbsp;</strong>refers to the presence of air or gas within the peritoneal cavity, the space within the abdomen that contains the intestines, liver, and other abdominal organs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Clinical Presentation and Diagnosis:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Patients with a significant amount of free air in the peritoneal cavity due to organ perforation often present with severe abdominal pain, signs of peritonitis (like guarding and rebound tenderness), and systemic symptoms like fever or shock. An erect abdominal X-ray is a commonly used diagnostic modality to detect pneumoperitoneum. On the X-ray, free air under the diaphragm, or \"free subdiaphragmatic air\", is a classic finding.</span></p>",
      "correct_choice_id": 56459,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5865,
      "choices": [
        {
          "id": 23430,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bilateral hydrosalpinx</span></span></span></p>"
        },
        {
          "id": 23431,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿Extravasation into venous system</span></span></span></p>"
        },
        {
          "id": 23432,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿Normal HSG</span></span></span></p>"
        },
        {
          "id": 23433,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿Bilateral cornual block</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the finding seen in this hysterosalpingogram?</span></span><span style=\"font-family:Helvetica,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (NEET PG 2020)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica\"><span style=\"font-family:Helvetica\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/03/untitled-349.jpg\" style=\"height:192px; width:300px\" /></span></span></span></span></span></p>",
      "unique_key": "Q3079883",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606902,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Bilateral hydrosalpinx </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The given HSG (hysterosalpingogram) film shows bilaterally enlarged Fallopian tubes, suggestive of bilateral hydrosalpinx. Hydrosalpinx is typically caused by the end result of repeated mild endo-salpingitis (inflammation of the fallopian tubes) by pyogenic organisms of low virulence but highly irritant.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The organisms involved include:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Staphylococcus</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">E. coli</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gonococcus</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chlamydia trachomatis</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mycobacterium tuberculosis</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">During the initial infection, the fimbriae become edematous and in-drawn with the serous surface, adhering together to produce closure of the abdominal ostium. The uterine ostium gets closed by congestion. This results in the secretion being pent up, causing the tube to distend. The distension is marked more in the ampullary region than in the more rigid isthmus. As the mesosalpinx is fixed, the resultant distension makes the tube curled and look &#39;retort&#39;-shaped. The wall is smooth and shiny, containing clear fluid inside, which is usually sterile.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Extravasation into venous system:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This would show contrast leaking into the venous system and not confined to the Fallopian tubes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Normal HSG:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A normal HSG would show patent Fallopian tubes without distension or blockage.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Bilateral cornual block:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This would show blockage at the cornua (the point where the Fallopian tubes enter the uterine cavity) without the dilated, fluid-filled appearance seen in hydrosalpinx.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hydrosalpinx is characterized by bilaterally enlarged Fallopian tubes filled with clear fluid, often due to repeated mild infections causing obstruction and distension.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 171, DC Dutta&rsquo;s Textbook of Gynecology, 6<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23430,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11125,
      "choices": [
        {
          "id": 44466,
          "text": "<p><span style=\"font-size:18px;\">Both sensitivity and specificity increase</span></p>"
        },
        {
          "id": 44467,
          "text": "<p><span style=\"font-size:18px;\">Both sensitivity and specificity decrease</span></p>"
        },
        {
          "id": 44468,
          "text": "<p><span style=\"font-size:18px;\">Sensitivity increases while specificity decreases</span></p>"
        },
        {
          "id": 44469,
          "text": "<p><span style=\"font-size:18px;\">Sensitivity decreases while specificity increases</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>A new diagnostic test for dengue is being evaluated using a Receiver Operating Characteristic (ROC) graph. As the curve transitions from the green region to the pink region, what is the most likely change in the test characteristics? </strong><i><strong>[AIIMS NOV 2017]</strong></i></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/23/ip30.jpg\" alt=\"\" width=\"532\" height=\"383\"></strong></span></p>",
      "unique_key": "Q1256811",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606903,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (a) Both sensitivity and specificity increase</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">As the curve transitions from green to pink, both sensitivity and specificity experience an increase.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\"><strong>Sensitivity</strong>: Ability of a screening test to identify correctly all those who have the disease (cases)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><i>Sensitivity = a/ (a + c) × 100 = TP/ (TP + FN) × 100</i></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\"><strong>Specificity</strong>: Ability of a screening test to identify correctly all those who do not have the disease (healthy)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><i>Specificity = d/ (b + d) × 100 = TN/ (TN + FP) × 100</i></span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-19-100044.png\" alt=\"\" width=\"400\" height=\"218\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">As the curve transitions from green to pink, it increases the count of true positives and negatives while decreases the occurrences of false positives and negatives. Consequently, this shift results in increased sensitivity and specificity.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-19-100216.png\" alt=\"\" width=\"700\" height=\"197\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">On an ROC graph, a transition from one region to another indicating improved test performance generally means that both sensitivity and specificity are increasing.</span></li></ul>",
      "correct_choice_id": 44466,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20928,
      "choices": [
        {
          "id": 83676,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Iron deficiency</span></span></span></span></p>"
        },
        {
          "id": 83677,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Zinc deficiency</span></span></span></span></p>"
        },
        {
          "id": 83678,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Calcium deficiency</span></span></span></span></p>"
        },
        {
          "id": 83679,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Copper deficiency</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A child presents with erythematous scaly patches in the perioral region, mucosal ulcers, and impaired epithelial wound healing. What is the likely mineral deficiency associated with this condition?(NEET PG 2023)</span></span></span></span></p>",
      "unique_key": "Q3649360",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606904,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Zinc deficiency</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The clinical features of periorificial dermatitis and stomatitis in a young child are suggestive of acrodermatitis enteropathica, seen in zinc deficiency.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/picture19.jpg\" style=\"height:335px; width:500px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Iron deficiency -</strong> Most common micronutrient deficiency globally. It presents with iron-deficiency anemia. It presents clinically with pallor, fatigue, weakness, shortness of breath, light-headedness.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Calcium deficiency -</strong> Leads to rickets in children. Apart from clinical vignette of rickets there can be Muscle cramps and stiffness, Tingling and Numbness, Tetany.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Copper deficiency -</strong> Leads to anemia, growth retardation, defective keratinization and pigmentation of hair, hypothermia, degenerative changes in aortic elastin, osteopenia, and neurological symptoms.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Zinc deficiency disorder- Acrodermatitis enteropathica</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/03/screenshot-2024-06-03-092648.jpg\" style=\"height:462px; width:1000px\" /></p>",
      "correct_choice_id": 83677,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61190,
      "choices": [
        {
          "id": 244041,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Radical Hysterectomy</span></span></span></p>"
        },
        {
          "id": 244042,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Conization</span></span></span></p>"
        },
        {
          "id": 244043,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chemoradiation</span></span></span></p>"
        },
        {
          "id": 244044,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Simple Hysterectomy</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 30-year-old woman presents to her gynecologist with an abnormal Pap smear that revealed carcinoma in situ (CIS) of the cervix, confirmed by colposcopy and biopsy. She has no visible macroscopic growth on examination, and her past medical history is unremarkable. She expresses concern about her fertility as she has not yet started a family. The gynecologist discusses the appropriate management options considering her age, fertility desires, and the stage of her disease. What is the recommended next step in management?</span></span></span></p>",
      "unique_key": "Q9163116",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606905,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. Conization</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Carcinoma in situ (CIS) of the cervix, also known as Stage 0 cervical cancer, involves the full thickness of the epithelial layer without invasion of the basement membrane. In a young woman like the patient described, conization is recommended because it serves a dual purpose: it provides a biopsy specimen to assess for any invasive disease and acts as a curative procedure by removing the lesion entirely. Conization is particularly suitable for women who wish to preserve fertility. If the woman&rsquo;s family is complete or in elderly patients, simple hysterectomy could be considered as an alternative approach.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Radical Hysterectomy</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Radical hysterectomy is not indicated for CIS, as it is an overly aggressive approach for a non-invasive condition. This option is reserved for more advanced stages of cervical cancer where there is clear invasion of surrounding tissues.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>C. Chemoradiation</strong>: Chemoradiation is reserved for more advanced stages of cervical cancer, such as those with bulky tumors or evidence of spread beyond the cervix. It is not appropriate for early, non-invasive lesions like CIS.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>D. Simple Hysterectomy</strong>: While simple hysterectomy could be considered in women who do not desire future fertility or are older, it is not the preferred option for younger patients who still wish to retain fertility. Conization is less invasive and sufficient in managing CIS.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Carcinoma in situ (Stage 0 cervical cancer) involves the full thickness of the cervical epithelium without basement membrane invasion. The preferred management in young women desiring fertility is conization, which serves both diagnostic and curative roles. More invasive procedures like radical hysterectomy or chemoradiation are reserved for more advanced disease stages.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/2.jpg\" style=\"height:318px; width:995px\" /></span></span></span></p>",
      "correct_choice_id": 244042,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54660,
      "choices": [
        {
          "id": 218105,
          "text": "<p><span style=\"font-size:12.0pt;\">4</span></p>"
        },
        {
          "id": 218106,
          "text": "<p><span style=\"font-size:12.0pt;\">5</span></p>"
        },
        {
          "id": 218107,
          "text": "<p><span style=\"font-size:12.0pt;\">6</span></p>"
        },
        {
          "id": 218108,
          "text": "<p><span style=\"font-size:12.0pt;\">7</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Calculate the Downe score of a newborn who has cyanosis which improves on giving oxygen, mild to moderate retractions, grunting heard on naked ear, air entry markedly decreased, RR 40 per minute?&nbsp;</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q5802424",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606906,
      "difficulty_level": "difficult",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;C) 6</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Downe score is used to assess the severity of respiratory distress in newborns. It consists of five components: cyanosis, retractions, grunting, air entry, and respiratory rate (RR). Each component is scored from 0 to 2, with a total possible score of 10. Here's the breakdown for the given case:</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/23/screenshot-2024-08-23-160859.png\" alt=\"\" width=\"1000\" height=\"941\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Summing up the scores:</span></p><p><br><span style=\"font-size:12.0pt;\">1 (cyanosis) + 1 (retractions) + 2 (grunting) + 2 (air entry) + 0 (RR) = 6</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Downe score is used to assess the severity of respiratory distress in newborns. A score of 6 in this case indicates moderate respiratory distress, characterized by cyanosis that improves with oxygen, mild to moderate retractions, grunting heard on naked ear, markedly decreased air entry, and a normal respiratory rate.</span></p>",
      "correct_choice_id": 218107,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10325,
      "choices": [
        {
          "id": 41266,
          "text": "<p><span style=\"font-size:12.0pt;\">Entamoeba Histolytica</span></p>"
        },
        {
          "id": 41267,
          "text": "<p><span style=\"font-size:12.0pt;\">Giardia lamblia</span></p>"
        },
        {
          "id": 41268,
          "text": "<p><span style=\"font-size:12.0pt;\">Helicobacter pylori</span></p>"
        },
        {
          "id": 41269,
          "text": "<p><span style=\"font-size:12.0pt;\">Entamoeba vermicularis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Flask shaped ulcers in the colon are caused by: (NEET PG 2019)</span></p>",
      "unique_key": "Q3591798",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606907,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Entameoba histolytica</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Flask shaped ulcers&nbsp;</strong>are classically seen in amoebiasis caused by Entamoeba histolytica.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/11_t6QZDZg.jpg\" alt=\"\" width=\"300\" height=\"199\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The most typical form of amoebic infection, amoebic colitis, starts as a tiny region of necrosis of mucosa that may ulcerate. These ulcerative lesions may grow, develop ulcer edge undermining from trophozoite lytic action, and have a necrotic bed. Due to their structure, such chronic amoebic ulcers are called flask-shaped ulcers (narrow neck and broad base). In addition to the presence of Entamoeba histolytica trophozoites, the ulcer's edge exhibits an inflammatory response with an admixture of polymorphonuclear and mononuclear cells.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/16/untitled-394.jpg\" alt=\"\" width=\"1000\" height=\"482\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Giardia lamblia:</strong> Causes giardiasis, affecting the small intestine and leading to malabsorption and diarrhea but not flask-shaped ulcers.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Helicobacter pylori:</strong> Associated with gastric and duodenal ulcers, not typically flask-shaped or located in the colon.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Entamoeba vermicularis:</strong> Incorrect nomenclature; possibly meant to refer to a helminth such as Enterobius vermicularis, which causes pinworm infections and does not lead to ulcer formation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Entamoeba histolytica is the cause of flask-shaped ulcers in the colon, distinguishing it from other intestinal pathogens due to its invasive capabilities and the characteristic morphology of the ulcers it creates. Understanding these features helps in the differential diagnosis of dysentery and guides appropriate treatment and management strategies.</span></p>",
      "correct_choice_id": 41266,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13756,
      "choices": [
        {
          "id": 54985,
          "text": "<p><span style=\"font-size:12.0pt;\">Ipecac</span></p>"
        },
        {
          "id": 54986,
          "text": "<p><span style=\"font-size:12.0pt;\">Penicillamine</span></p>"
        },
        {
          "id": 54987,
          "text": "<p><span style=\"font-size:12.0pt;\">Activated charcoal</span></p>"
        },
        {
          "id": 54988,
          "text": "<p><span style=\"font-size:12.0pt;\">Dimercaprol</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Treatment of choice for acute arsenic poisoning is? (</span>INICET May 2022)</p>",
      "unique_key": "Q5226491",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606908,
      "difficulty_level": "intermediate",
      "subjects_id": [
        10
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Dimercaprol</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Dimercaprol is a traditional chelating agent of choice for acute arsenic poisoning. Though now DMSA and DMPS are considered better, as they can be given orally and have lower toxicity. Amongst the given choices, dimercaprol is best answer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Ipecac:&nbsp;</strong>Ipecac is rapidly acting anti-emetic. Earlier it was sometimes used to remove different types of unabsorbed poisons in GIT, but now it is no longer recommended due to limited benefits</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Penicillamine:&nbsp;</strong>Though it can be used in arsenic, but not a preferred agent. It is preferred chelator for copper.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Activated charcoal:&nbsp;</strong>Not useful as it does not adsorb arsenic and other heavy metals</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Treatment of Acute Arsenic poisoning</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Hemodynamic stabilization for significant GI losses (vomiting and diarrhea)</span></li><li><span style=\"font-size:12.0pt;\">Gastric lavage is done repeatedly with large amount of warm water and milk;</span></li><li><span style=\"font-size:12.0pt;\"><strong>Chelating Agents</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Chelating agents are useful in acute arsenic poisoning, but have very limited role in chronic arsenic poisoning</span></li><li><span style=\"font-size:12.0pt;\">There are three chelating agents useful in acute arsenic poisoning:</span><ol><li><span style=\"font-size:12.0pt;\"><strong>British Anti Lewisite</strong> (BAL, aka dimercaprol, dimercaptopropanol): available in IM route. Traditionally BAL was used most commonly for As, but now DMSA and DMPS are considered better, as they can be given orally and have lower toxicity.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Dimercaptosuccinic acid</strong> (DMSA, aka succimer): available Orally</span></li><li><span style=\"font-size:12.0pt;\"><strong>Dimercaptopropanesulfonic acid</strong> (DMPS, aka Dimerval): available Oral, IM and IV. DMPS is agent of choice for acute As poisoning.</span></li></ol></li></ul></li></ul>",
      "correct_choice_id": 54988,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14551,
      "choices": [
        {
          "id": 58165,
          "text": "<p><span style=\"font-size:18px;\">Gallstone ileus</span></p>"
        },
        {
          "id": 58166,
          "text": "<p><span style=\"font-size:18px;\">Adhesive intestinal obstruction</span></p>"
        },
        {
          "id": 58167,
          "text": "<p><span style=\"font-size:18px;\">Ischemic enterocolitis</span></p>"
        },
        {
          "id": 58168,
          "text": "<p><span style=\"font-size:18px;\">Diverticulitis</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\">A 51-year-old woman who had an abdominal hysterectomy two years ago and is now experiencing abdominal pain, vomiting bile, high-pitched bowel sounds during examination. The presence of air within the biliary tree is seen on diagnostic tests.&nbsp;What is the most likely diagnosis?&nbsp;(NEET PG 2021)</span></p>",
      "unique_key": "Q4012658",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606909,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. A) Gallstone ileus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The given clinical scenario is suggestive of intestinal obstruction. Though adhesions could be the reason, the presence of air in biliary tree makes a diagnosis of gallstone ileus more likely.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Gallstone ileus is a rare complication of cholelithiasis, occurring due to the impaction of gallstones in the gastrointestinal tract. This occurs due to chronic gall bladder inflammation and formation of cholecysto-duodenal fistula (GB to duodenum). Through the communication, a gall stone may pass into the duodenum and then into small bowel.</span></li><li><span style=\"font-size:18px;\">Small gallstones may pass through the intestines spontaneously, but larger stones (2-5 cm) are more likely to cause obstruction, usually at the terminal ileum or ileocecal valve.</span></li><li><span style=\"font-size:18px;\">Symptoms may include acute, intermittent, or chronic episodes of gastrointestinal obstruction, abdominal distension and tenderness, high-pitched bowel sounds, and obstructive jaundice.</span></li><li><span style=\"font-size:18px;\">Diagnosis is typically made with a plain abdominal radiograph, which may show signs of obstruction, Pneumobilia (air within the biliary tree), and a gallstone in the intestines (RIGLER’S TRIAD).</span></li><li><span style=\"font-size:18px;\">Treatment involves surgical intervention, with a longitudinal incision made on the antimesenteric border to remove the gallstone.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>&nbsp;Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B</strong>. <strong>Adhesive intestinal obstruction: </strong>This results from the formation of adhesions (bands of scar tissue) that can develop after surgery, which then bind the intestines together. These adhesions can pull the intestines out of place or create a kink or twist. The patient's history of an abdominal hysterectomy is suggestive of this, as post-surgical adhesions are a common cause of intestinal obstruction. However, the presence of air in the biliary tree does not fit with this diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C</strong>. <strong>Ischemic enterocolitis: </strong>Refers to inflammation of the intestine due to reduced blood supply, often caused by blockage or constriction of the blood vessels that serve the intestines. Symptoms typically include sudden abdominal pain and bloody diarrhea. While ischemic processes can cause pain and altered bowel sounds, the presence of pneumobilia on imaging is not consistent with ischemic enterocolitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D</strong>. <strong>Diverticulitis</strong>: Diverticulitis is the inflammation of one or more diverticula, which are small pouches that can form in the walls of the colon. Symptoms include lower left-sided abdominal pain, fever, and changes in bowel habits. While diverticulitis can lead to complications like abscesses, fistulas, or bowel obstructions, the specific presentation of vomiting bile and air within the biliary tree on imaging is not consistent with a primary diagnosis of diverticulitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Gallstone ileus is a rare complication of cholelithiasis characterized by the presence of air within the biliary tree, obstructive symptoms, and the formation of a cholecysto-duodenal fistula.</span></li><li><span style=\"font-size:18px;\">It typically presents with signs of gastrointestinal obstruction and is diagnosed through imaging, revealing pneumobilia and a gallstone in the intestines.</span></li></ul>",
      "correct_choice_id": 58165,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/14551/Mini_Gt_5_Radiology_Q_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/14551/Mini_Gt_5_Radiology_Q_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 577,
      "choices": [
        {
          "id": 2304,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FEV1 &lt; 0.85 and FEV1/FVC &lt;0.8</span></span></span></p>"
        },
        {
          "id": 2305,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FEV1 &lt; 0.85 and FEV1/FVC &lt;0.75</span></span></span></p>"
        },
        {
          "id": 2306,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FEV1 &lt; 0.8 and FEV1/FVC &lt;0.7</span></span></span></p>"
        },
        {
          "id": 2307,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FEV1 &lt; 0.8 and FEV1/FVC &lt;0.75</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 60-year-old male patient has grade III ASA. Which of the following post bronchodilator PFT findings requires further evaluation of the lung function of the patient? (</span></span></span>INICET Nov 2021)</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ASA- American Society of Anesthesiology</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PFT- Pulmonary function test</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FEV1 - Forced expiratory volume in 1 second</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FVC- Forced vital capacity</span></span></span></p>",
      "unique_key": "Q4715111",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606910,
      "difficulty_level": "intermediate",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. FEV1 &lt; 0.8 and FEV1/FVC &lt;0.7</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This option shows a significant reduction in both FEV1 and the FEV1/FVC ratio. An FEV1/FVC ratio of less than 0.7 is a clear indicator of obstructive lung disease. Combined with the reduced FEV1, this suggests significant lung dysfunction that requires further evaluation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. FEV1 &lt; 0.85 and FEV1/FVC &lt;0.8:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While these values indicate some reduction in lung function, they do not meet the threshold for a definitive diagnosis of obstructive lung disease. The FEV1/FVC ratio is still above the critical cutoff of 0.7.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. FEV1 &lt; 0.85 and FEV1/FVC &lt;0.75:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> These values suggest reduced lung function but not to the extent that is indicative of moderate or severe COPD. The FEV1/FVC ratio is below 0.8 but not yet at the critical threshold of 0.7.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. FEV1 &lt; 0.8 and FEV1/FVC &lt;0.75:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While the FEV1 is below 0.8, the FEV1/FVC ratio is not at the critical threshold of 0.7, so it does not indicate significant obstructive lung disease requiring further evaluation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective :</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">As per GOLD criteria for COPD, FEV1 &lt;0.8 and FEV1/FVC &lt;0.7 are classified as moderate COPD and require further evaluation of lung function.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">GOLD criteria for COPD is given as follows:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/06/screenshot-2024-07-06-150644.jpg\" style=\"height:282px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Abbreviations</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: COPD, chronic obstructive pulmonary disease; GOLD, Global Initiative for Lung Disease </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">As per GOLD criteria for COPD, FEV1 &lt;0.8 and FEV1/FVC &lt;0.7 are classified as moderate COPD and require further evaluation of the lung function.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Miller&rsquo;s Anesthesia, 9<sup>th</sup> Ed. Pg</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>950</strong></span></span></p>",
      "correct_choice_id": 2306,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14427,
      "choices": [
        {
          "id": 57669,
          "text": "<p><span style=\"font-size:12.0pt;\">Platelet transfusion</span></p>"
        },
        {
          "id": 57670,
          "text": "<p><span style=\"font-size:12.0pt;\">Arrange PRBC</span></p>"
        },
        {
          "id": 57671,
          "text": "<p><span style=\"font-size:12.0pt;\">IV Octreotide</span></p>"
        },
        {
          "id": 57672,
          "text": "<p><span style=\"font-size:12.0pt;\">Urgent Endoscopy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old male patient with a history of liver cirrhosis presents to the emergency room with active variceal bleeding. Which of the following interventions is not typically performed in this situation?</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">(AIIMS NOV 2019)</span></p>",
      "unique_key": "Q7726419",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606911,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Platelet transfusion</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Platelet transfusion is not typically performed as an immediate intervention for variceal bleeding. Platelets are responsible for blood clotting, but variceal bleeding is primarily caused by the rupture of dilated blood vessels (varices) in the esophagus or stomach, which is related to portal hypertension.</span></li><li><span style=\"font-size:12.0pt;\">Platelet transfusions are usually considered when a patient with liver cirrhosis has significant thrombocytopenia (low platelet count) or when there is an underlying bleeding disorder. However, they are not the primary treatment for variceal bleeding.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Arrange PRBC (packed red blood cell) transfusion</strong>: PRBC transfusion is often necessary to replace lost blood and stabilize the patient's hemodynamic status. Active variceal bleeding can lead to significant blood loss, and transfusion of red blood cells is a crucial part of resuscitation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. IV Octreotide</strong>: IV Octreotide is commonly administered in cases of active variceal bleeding. Octreotide is a medication that helps reduce portal pressure by constricting blood vessels, including those in the varices. This can help control the bleeding until more definitive treatment, such as endoscopy or interventional radiology procedures, can be performed.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Urgent Endoscopy</strong>: Urgent endoscopy, typically performed within 12-24 hours, is a critical intervention in the management of variceal bleeding. During endoscopy, a gastroenterologist can identify the source of bleeding and perform interventions such as band ligation or sclerotherapy to stop the bleeding.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Management of variceal bleeding:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Initial resuscitation: The first step in the management of variceal bleeding is to stabilize the patient with aggressive resuscitation measures, including airway management, fluid and blood product resuscitation, and correction of coagulopathy.</span></li><li><span style=\"font-size:12.0pt;\">Endoscopy: Early endoscopy allows for the identification of the bleeding site and the application of endoscopic therapies such as band ligation or sclerotherapy.</span></li><li><span style=\"font-size:12.0pt;\">Pharmacological therapy: Vasopressin and its analogs (such as terlipressin) are commonly used in the management of variceal bleeding to decrease portal pressure and reduce the risk of re-bleeding.</span></li><li><span style=\"font-size:12.0pt;\">Antibiotics: Prophylactic antibiotics are recommended in patients with variceal bleeding to reduce the risk of bacterial infections, such as spontaneous bacterial peritonitis.</span></li><li><span style=\"font-size:12.0pt;\">Transjugular intrahepatic portosystemic shunt (TIPS): In patients with recurrent bleeding despite endoscopic and pharmacological therapy, TIPS may be considered to reduce portal pressure and prevent further bleeding.</span></li><li><span style=\"font-size:12.0pt;\">Surgery: In rare cases, surgical intervention may be necessary to control variceal bleeding, particularly in patients with refractory bleeding or severe liver disease.</span></li></ul>",
      "correct_choice_id": 57669,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6491,
      "choices": [
        {
          "id": 25933,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">5HT4 agonist</span></span></span></p>"
        },
        {
          "id": 25934,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dopamine antagonist</span></span></span></p>"
        },
        {
          "id": 25935,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Macrolides</span></span></span></p>"
        },
        {
          "id": 25936,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Diphenylmethane</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is not a prokinetic?</span></span> <span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(NEET PG 2020)</span></span></p>",
      "unique_key": "Q2668552",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606912,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Diphenylmethane</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Diphenylmethane is not a prokinetic drug. It is a type of organic compound that is not used for the treatment of gastrointestinal motility disorders.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A prokinetic drug is a medication that increases gastrointestinal motility and promotes the movement of food through the digestive system. 5HT4 agonists, dopamine antagonists, and macrolides are all types of prokinetic drugs. </span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. 5HT4 agonists</span></strong><span style=\"font-size:12.0pt\"> stimulate the release of serotonin in the gut, which enhances gastrointestinal motility. </span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Dopamine antagonists</span></strong><span style=\"font-size:12.0pt\"> block the action of dopamine in the gut, which can increase gastrointestinal motility. </span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Macrolides</span></strong><span style=\"font-size:12.0pt\"> have antimicrobial properties and also act as motilin receptor agonists, which promote gastrointestinal motility.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Diphenylmethane is not a prokinetic drug and is not used to treat gastrointestinal motility disorders. Prokinetic drugs include 5HT4 agonists, dopamine antagonists, and macrolides, which all act to enhance gastrointestinal motility.</span></span></span></p>",
      "correct_choice_id": 25936,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 472,
      "choices": [
        {
          "id": 1884,
          "text": "<p>1</p>"
        },
        {
          "id": 1885,
          "text": "<p>7</p>"
        },
        {
          "id": 1886,
          "text": "<p>9</p>"
        },
        {
          "id": 1887,
          "text": "<p>4</p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient came with complaints of inability to move his 4th and 5th digit, cannot hold a pen and he was not able to hold a paper between fingers. Which of the following sites given below is the probable cause of injury to the nerve in question? (</span>AIIMS Nov 2017)</p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:center;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/25/inicet-anat-2017-23.jpg\" alt=\"\" width=\"200\" height=\"324\"></span></p>",
      "unique_key": "Q7106479",
      "question_audio": null,
      "question_video": null,
      "map_id": 13606913,
      "difficulty_level": "beginner",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. 7</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given clinical scenario of a patient complaining of inability to move his 4<sup>th</sup> and 5<sup>th</sup> digit, not able to hold a pen and also not able to hold paper between fingers, all together suggests towards an ulnar nerve injury. The most likely site of injury would thus be medial epicondyle – structure marked as 7.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Given below is the labelling of the structures marked in the figure -</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Head</span></li><li><span style=\"font-size:12.0pt;\">Greater Tubercle</span></li><li><span style=\"font-size:12.0pt;\">Intertubercular Groove</span></li><li><span style=\"font-size:12.0pt;\">Deltoid Tuberosity</span></li><li><span style=\"font-size:12.0pt;\">Capitulum</span></li><li><span style=\"font-size:12.0pt;\">Trochlea</span></li><li><span style=\"font-size:12.0pt;\">Medial Epicondyle</span></li><li><span style=\"font-size:12.0pt;\">Olecranon Fossa</span></li><li><span style=\"font-size:12.0pt;\">Lateral Epicondyle</span></li><li><span style=\"font-size:12.0pt;\">Lesser Tubercle</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. 1: Head of Humerus:</strong> This area is not typically associated with isolated ulnar nerve injuries. Injuries here affect the axillary nerve.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. 9: Lateral Epicondyle:</strong> The lateral epicondyle is more commonly associated with injuries affecting the radial nerve or conditions like lateral epicondylitis (tennis elbow).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. 4: Deltoid Tuberosity:</strong> This site on the humerus is typically associated with the attachment of the deltoid muscle. Injuries or issues here would more likely affect the deltoid muscle or the radial nerve dysfunction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Tests for ulnar nerve lesions are as follows:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. Card Test</strong>: This isn't a widely recognized test in the context of ulnar nerve pathology. However, in some practices, the card test might refer to asking the patient to hold a card (like a credit card) between their thumb and the side of their index finger. Difficulty or inability to do this due to a weak adductor pollicis muscle (innervated by the ulnar nerve) may suggest ulnar nerve dysfunction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>2. Claw Hand Deformity</strong>: This is seen in ulnar nerve injuries. In a typical ulnar claw hand, the 4th and 5th digits (ring and little fingers) are hyperextended at the metacarpophalangeal (MCP) joints and flexed at the interphalangeal (IP) joints. This occurs due to the loss of function of the lumbricals and interossei of the hand, which are innervated by the ulnar nerve.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>3. Froment's Sign</strong>: This is a classic sign of ulnar nerve palsy. The patient is asked to hold a piece of paper between their thumb and the side of their index finger (pinch grip). If the ulnar nerve is compromised, the patient will compensate by flexing the thumb's IP joint to maintain grip strength, which is a positive Froment's sign. This indicates weakness or paralysis of the adductor pollicis muscle.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>4. Wartenberg Sign</strong>: In ulnar nerve injury, there's unopposed action of the extensor digiti minimi, which leads to abduction of the little finger. The patient will be unable to bring their little finger back to the side of the hand, leading to the \"Wartenberg sign.\"</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>5. Palmaris Brevis Sign</strong>: This is a sign of ulnar nerve functionality. The palmaris brevis muscle is innervated by the ulnar nerve. Upon tapping or massaging the hypothenar eminence (palm side of the hand, base of the little finger), contraction of the palmaris brevis muscle can be observed as a twitching or dimpling. If present, it indicates that at least part of the ulnar nerve's function remains intact.</span></p>",
      "correct_choice_id": 1885,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}